Next Article in Journal
Oxidative Stress Induces Bovine Endometrial Epithelial Cell Damage through Mitochondria-Dependent Pathways
Next Article in Special Issue
Edwardsiella tarda in Tambaqui (Colossoma macropomum): A Pathogenicity, Antimicrobial Susceptibility, and Genetic Analysis of Brazilian Isolates
Previous Article in Journal
Prevalence of Echocardiographic Evidence of Trace Mitral and Aortic Valve Regurgitation in 50 Clinically Healthy, Young Adult Labrador Retrievers without Heart Murmur
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Streptococcosis a Re-Emerging Disease in Aquaculture: Significance and Phytotherapy

1
Department of Animal and Aquatic Sciences, Faculty of Agriculture, Chiang Mai University, Chiang Mai 50200, Thailand
2
Science and Technology Research Institute, Chiang Mai University, 239 Huay Keaw Rd., Suthep, Muang, Chiang Mai 50200, Thailand
3
Centre for Sustainable Aquatic Ecosystems, Harry Butler Institute, Murdoch University, Perth, WA 6150, Australia
4
Department of Aquatic Animal Health, Faculty of Veterinary Medicine, University of Tehran, Tehran 1419963111, Iran
5
Environmental Sciences Center, Qatar University, Doha P.O. Box 2713, Qatar
6
Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, Shahrekord University, Shahrekord 64165478, Iran
7
Department of Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran 1419963111, Iran
8
Norwegian College of Fishery Science, Faculty of Bioscience, Fisheries and Economics, UiT The Arctic University of Norway, 18, 9019 Tromsø, Norway
*
Author to whom correspondence should be addressed.
Animals 2022, 12(18), 2443; https://doi.org/10.3390/ani12182443
Submission received: 27 August 2022 / Revised: 7 September 2022 / Accepted: 12 September 2022 / Published: 16 September 2022
(This article belongs to the Special Issue Bacterial and Viral Diseases in Aquatic Animals)

Abstract

:

Simple Summary

Streptococcosis is an economical important bacterial disease that can seriously cause huge losses in the global aquaculture sector. In recent years studies have focused on to use extracts or essences of medicinal herbs and plants to control or treat the disease outbreaks and, in most cases the results were promising. The essential oils of the herbs or plants are more effective than the extracts and, the extracts examined have moderate efficacy in term of increasing fish survival against fish streptococcosis that could be due to the enhancement of fish immunity by the herb bio-compounds. The lack of dosage optimization, toxicity and bioavailability assays of a specific herb/plant or its bioactive compound in fish organs make it difficult to judge the validation of clinical efficacy of a particular herb/plant against fish streptococcosis, and thus, required further investigations.

Abstract

Streptococcosis, particularly that caused by S. iniae and S. agalactiae, is a major re-emerging bacterial disease seriously affecting the global sustainability of aquaculture development. Despite a wide spread of the disease in aquaculture, few studies have been directed at assessing the in vitro antagonistic activity and in vivo efficacy of medicinal herbs and other plants against streptococcal agents. Most in vitro studies of plant extractives against S. iniae and S. agalactiae have found antibacterial activity, but essential oils, especially those containing eugenol, carvacrol or thymol, are more effective. Although essential oils have shown better anti-streptococcal activity in in vitro assays, in vivo bioassays require more attention. The extracts examined under in vivo conditions show moderate efficacy, increasing the survival rate of infected fish, probably through the enhancement of immunity before challenge bioassays. The available data, however, lack dosage optimization, toxicity and bioavailability assays of a specific plant or its bioactive compound in fish organs; hence, it is difficult to judge the validation of clinical efficacy for the prevention or treatment of fish streptococcosis. Despite the known bioactive compounds of many tested plants, few data are available on their mode of action towards streptococcal agents. This review addresses the efficacy of medicinal plants to fish streptococcosis and discusses the current gaps.

1. Introduction

Infections by Streptococcus species, Streptococcus iniae, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, Streptococcus parauberis, and Streptococcus phocae, are serious re-emerging bacterial diseases in humans and a wide range of terrestrial animals, fish, and marine mammals. Fish streptococcosis is one of the major infectious diseases in freshwater and marine aquaculture, affecting the sustainability of aquaculture development worldwide [1,2], and is also a zoonotic disease, with important food safety implications [3,4,5,6]. Even though vaccines have shown positive results, they are not adequately efficacious due to the wide heterogeneity of bacterial species/strains involved in the infections [7]. Consequently, fish streptococcal infections are often treated with various antibiotics, such as florfenicol, erythromycin, doxycycline and oxytetracycline [8,9,10,11]. However, due to re-infections by the pathogens, frequent treatments are required, causing major problems, including the accumulation of antibiotics in fish carcasses [12] and the release of drugs into aquatic ecosystems, increasing the likelihood of bacterial resistance [13,14,15,16,17].
Due to global demand for chemical-free aquaculture products [16,18], there is increasing interest in the use of dietary supplements or additives capable of improving fish health [19,20]. Medicinal herbs and other plants are potentially good alternatives to replace chemical substances in aquaculture due to numerous benefits, including improved growth performance, antioxidant activity, physiological conditions, and welfare status [21,22,23,24,25,26,27], antimicrobial and immune effects [28,29,30,31,32,33], and hepatoprotective effects [30,34]. Furthermore, medicinal plants are readily available, inexpensive, and more biodegradable compared to synthetic chemical compounds [35,36]. Consequently, numerous plants have been studied as treatment or preventative agents against fish streptococcosis (e.g., [20,37,38,39,40,41,42]). This review addresses the significance of fish streptococcosis and the potential for phytotherapy as an alternative to antibiotics, with a discussion of knowledge gaps and future research requirements. For clarity, the readers can refer to Table 1, Table 2, Table 3, Table 4, Table 5, Table 6 and Table 7 for details of the in vitro antagonistic effects and in vivo treatment efficacy of plants and plant products, and we will avoid excessive reference to these tables in the text.

2. The Disease

Species in the genus Streptococcus belong to the Order Lactobacillales (lactic acid bacteria) and are Gram-positive, spherical or ovoid, non-spore-forming, non-motile and facultative anaerobic bacteria. They have been isolated from water and from the gastrointestinal (GI) tracts of various animals, such as humans, cattle, chickens, dogs, cats, hamsters, mice, monkeys, nutria, camels, horses, sheep, goat, bottlenose dolphins, fish, frogs and seals [43,44,45,46]. Streptococcosis is the general term for a variety of diseases caused by members of the genus Streptococcus. In fish, streptococcosis is mostly reported for infections with S. iniae, S. agalactiae and S. dysgalactiae [47,48,49]. S. iniae is one of the leading fish pathogens in freshwater and saltwater aquaculture species, especially in warmer regions. The bacterium is β-hemolytic on 5% sheep blood agar, but it cannot be grouped by the Lancefield antigen method typically used to categorize Streptococcus species. S. agalactiae is β-hemolytic and carries the Lancefield group B antigen. S. dysgalactiae is mostly non-beta hemolytic, with the Lancefield group C antigen.
Lethargy, loss of appetite, skin discoloration, exophthalmia/corneal opacity, abdominal distention and abnormal behavioral swimming are the most common clinical signs of streptococcosis in infected fish [9,47,50,51,52,53,54,55,56,57,58]. These clinical signs are not pathognomonic because they are not distinct from lactococcosis caused by Lactococcus garvieae, at least in some high susceptible species such as rainbow trout (Oncorhynchus mykiss) [59]. Other occasional macroscopical findings such as skin and fin hemorrhage, dorsal rigidity, vertebral deformity, tachypnoea and subcutaneous edema with ulceration are also reported in various degrees, but mostly in fish infected with S. iniae, S. agalactiae and S. dysgalactiae. The size and severity of the clinical signs are, however, varied and are dependent on a range of factors including fish species and size, bacterial virulence and health management criteria, particularly water temperature and dissolved oxygen (e.g., [9,47,60]). Internally, affected fish may show ascitic fluid in the abdominal cavity; the enlargement of liver and spleen; fibrinous pericarditis and peritonitis, hemorrhages in tissues of the brain, retrobulbar region, intestines and liver; and the congestion of the spleen and kidney in various degrees [50,56,58,61,62]. The clinical presentations are, however, known to be more severe in fish infected with capsulated strains of S. iniae and S. agalactiae, particularly in susceptible fish species such as rainbow trout and tilapia (Oreochromis niloticus).
The observation of intracellular bacteria in various external and internal organs are a clear sign of generalized bacterial septicemia in infected fish, and the most common histopathological findings due to S. iniae, S. agalactiae and S. dysgalactiae have been reported in tissues of the brain, heart and eyes of affected fish with marked pericarditis, choroiditis and meningitis [47,52,55,56,62]. Affected fish can, however, develop various other pathological findings, including keratitis, hemorrhagic or granulomatous meningoencephalitis, interstitial nephritis, branchitis, splenitis, ophthalmitis, choroiditis, hepatitis, gastritis, enteritis, pancreatitis, peritonitis, skeletal muscle myositis and fasciitis, and ulcerative and hyperemic dermatitis, as well as granulomatous reactions and inflammatory responses [47,50,56,61]. In addition, other tissues including liver, kidney, spleen, heart and gill may be affected, showing necrosis and hemorrhage [9,52,55,56,62,63]. Little information is available, however, on the pathology of other streptococcal infections in fish. Macrophage infiltration in kidney, liver and muscle, focal necrosis in muscle fibers in freshwater fish infected with S. parauberis [57] and large numbers of vacuoles in the brain matrix of fish infected with S. uberis have been reported [58], but no microscopic pathology data are available for S. phocae infections in fish [53,64].

2.1. Pathogenesis

The mechanism of pathogenesis and virulence factors involved in the disease caused by streptococcal species in affected fish is not yet fully understood. After the colonization and multiplication of the external (skin, fin, gills or nares) or gastrointestinal tissues, the bacteria invade internal tissues and blood, causing a generalized bacteremia followed by a septicemic condition induced by bacterial toxins. In fish infected with S. iniae, infection of the central nervous system (CNS) causing meningitis can occur through the entrance of bacteria via the blood circulation system or by contaminated monocytes/phagocytes with bacterial cells, and the incidence of CNS infection was correlated with the bacterial concentration in the blood and the duration of the bacteremia [65]. As some fish infected with S. iniae can carry the pathogen asymptomatically with no clinical signs [66], further research required to understand the mechanism of pathogenesis in more detail.
Several virulence factors are reported in Streptococcus species, but these are mostly detected in strains isolated from terrestrial animals. In fish, most virulence factors have been reported for S. iniae, S. agalactiae and S. dysgalactiae, and scarce data are available for other streptococcal species. The capsular polysaccharides are thought to be one of the most important virulence factors, inducing resistance to phagocytosis and the host humoral immune responses [10,47,67,68,69]. The survival of pathogens at the intracellular stage can facilitate the progression from a local to a systemic infection [70,71], and virulent isolates expressing a completed polysaccharide capsule are more resistant to phagocytosis than other strains [69]. Some non-capsulated strains [67] are more virulent to fish, however, suggesting that intra-phagocytic survival may not be a primary mechanism of disease establishment in fish; thus, further investigations are required.
The enhancement of the apoptosis of infected cells may also assist disease establishment, as it can cause cell death without the release of cellular components, resulting in the suppression of the host inflammation responses [47]. Some strains of S. iniae, such as serotype II, have capsules with more surface antigens, which can present additional anti-phagocytic properties [67,72]. A cell surface Fc binding factor, which blocks the binding and activation of complement cascade, has also been demonstrated to be part of S. iniae pathogenesis [73]. Further, M-like protein for cell adhesion, phosphoglucomutase for sugar metabolism, streptolysin S (SLS) for the synthesis of the SLS structural peptide and the SLS modification protein, peptidoglycan deacetylase for peptidoglycan acetyl modification, cell envelope proteinase for the synthesis of IL-8-cleaving cysteine protease and SivR/S for the two-component transcriptional regulation system encoded by different genes (i.e., simA, pgmA, sagA–sagI, agA, agB, PDI, cepI and SivR/S) have been confirmed as virulence factors of S. iniae strains [67,69,74,75,76,77,78,79,80]. Furthermore, the C5a peptidase [78] and fibrinogen binding protein [81], and recently two novel virulence factors, an extracellular nuclease and a secreted nucleotidase, probably with enzymatic activities, have been identified in strains of S. iniae that were involved in the experimental infection of zebrafish [80].
Several virulence factors have been identified in pathogenic S. agalactiae strains, including pore-forming toxins [β-hemolysin/cytolysin, CAMP factor (a protein B that enlarges the area of hemolysis formed by the β-hemolysin elaborated from the bacterium)], factors for immune evasion (sialic acid capsular polysaccharide, C5a peptidase, serine protease), superoxide dismutase, D-alanylated lipoteichoic acid, adhesins, hyaluronate lyase, and methionine transport regulator [82,83,84]. Most of these factors, however, have been studied in strains recovered from infected terrestrial animals, and thus virulence factors in strains infecting fish require further research. Despite the transmission of the pathogen from mother to newborn being an important risk factor of infection and disease progression for S. agalactiae in humans [85], no data are available on the vertical transmission of this pathogen in susceptible oviparous or viviparous fish species.
In S. dysgalactiae, the M-like protein is the most extensively studied virulence factor. This protein can opsonize both adherence to and entrance into host cells [86,87] and aids in immune evasion by inhibiting phagocytic activity and inactivating the complement cascade [87]. Adhesins encoded by different bacterial genes (gfba, fnB, fbBA, fnBB, lmb and gapC) are known to mediate binding to fibronectin [88,89,90,91], and the gfba gene can also assist bacterial entry into host endothelial cells and intracellular persistence [92,93]. Most adhesins, however, are recognized in strains of S. dysgalactiae isolated from affected human and other warm-blooded animals. In addition, protein G, a known virulent factor in S. dysgalactiae strains, can bind with circulating immunoglobulins and, hence, interfere with the host humoral immune response [94]. Furthermore, several toxins and secreted enzymes, including the hemolysins, streptolysin O and SLS [95,96] and superantigen speG [97], the streptokinase enzyme that enables the hydrolysis of fibrin and aids in bacterial spreading through tissues [87], have been identified in virulent isolates of S. dysgalactiae.
Several potential virulence factors, including hyaluronic acid capsule, hyaluronidase, uberis factor, antiphagocytic factors (capsule, neutrophil toxin, M-like protein and R-like protein), plasminogen activator/streptokinase factor, surface dehydrogenase protein, CAMP factor, lactoferrin binding protein and surface adhesion molecule, have been identified in both S. uberis and S. parauberis in warm-blooded animals [98,99,100], but these factors have never been studied in strains isolated from diseased fish. Some strains of S. parauberis carrying capsuled polysaccharide genes have recovered from diseased fish [101], but the role of other virulent factors in the pathogenicity of these species needs further study.
The capacity to form biofilms has been reported for S. iniae, S. dysgalactiae, S. uberis and S. parauberis. Biofilms can facilitate the survival and proliferation of bacteria in hostile environments, such as aquaculture recirculation bio-filtration systems [99,102,103], probably due to the bacterial extracellular production.
Virulence factors of S. phocae are mostly studied in marine mammals and rarely in fish species. Strains of S. phocae with antiphagocytic capsule ability are identified in experimental infections of Atlantic salmon (Salmo salar) [53,104,105]. In another study by González-Contreras et al. [106], cell-surface-related properties, including capsule detection, adhesion and hydrophobicity to fish mucus and cell lines, biofilm formation in skin mucus and serum resistance, were demonstrated in S. phocae isolates responsible for outbreaks in Atlantic salmon. More detailed studies of these properties are, however, required, as no mortalities or histopathological findings were seen in the fish injected with extracellular products. Other virulence factors, including fibronectin-binding proteins, the toxin SLS, genes encoding for a capsule [107] and the ability of the bacterium to invade fish and mammalian cell lines were also detected as part of S. phocae pathogenesis in aquatic animals, but these studies have mostly been in marine mammalians [104].

2.2. Disease Significance in Aquaculture

Despite the wide spread of infection in aquaculture, there are no recent estimates of annual losses by streptococcal pathogens in the industry [84]. The annual estimated losses caused by Streptococcosis were 150 and 250 million USD in 2000 and 2008, respectively [15,105,106]. In Iran, rainbow trout production in freshwater is remarkably high (about 180000 tons), but the annual loss through streptococcosis is estimated at around 30%, due to high water temperature in summer and poor health management [10,60,107,108]. Many fish species in freshwater, estuarine and marine environments are susceptible to S. iniae, and rainbow trout, yellow tail (Seriola quinqueradiata), Asian seabass (Lates calcarifer) and Nile tilapia (Oreochromis niloticus) are highly susceptible species (e.g., [9,47,50,105,109,110]).
Streptococcus agalactiae is a globally emerging fish pathogen causing huge economic losses in many freshwater and saltwater species [44]. The bacterium is reported in rainbow trout, seabream, tilapia, yellowtail, several species of catfish and mullet, croaker (Micropogonius undulatus), killfish (Menhaden spp.) and silver pomfret (Pampus argenteus) [44,51,52,111,112,113,114,115].
The first outbreak by the α-hemolytic Lancefield group C S. dysgalactiae subsp. dysgalactiae was reported in vaccinated and non-vaccinated farmed amberjack/yellowtail in Japanese fish farms [116]. Later, the pathogen was detected in kingfish (Seriola lalandi), grey mullet (Mugil cephalus), basket mullet (Liza alata), cobia (Rachycentron canadum), hybrid red tilapia (Oreochromis sp.), pompano (Trachinotus blochii), white spotted snapper (Lutjanus stellatus), Amur sturgeon (Acipenser schrenckii), golden pomfret (Trachinotus ovatus) and Nile tilapia from Brazil, Japan, China, Malaysia, Indonesia, Taiwan and Iran [28,54,117,118,119].
The first study reporting streptococcosis infection by S. parauberis (formerly known as S. uberis type II) [120] in fish was revealed by Domeénech et al. [121]. Subsequently, the disease was reported in several species including turbot (Scophthalmus maximus), olive flounder, sea bass (Sebastes ventricosus), striped bass (Morone saxatilis) and ram cichlid (Mikrogeophagus ramirezi) [57,122,123,124,125]. More recently, S. parauberis classified as serotype III has been reported as the cause of streptococcosis in different turbot farms in China, and the isolates are different from those that infect flounder (Paralichthys olivaceus) in Japan and South Korea but similar to strains in Spain and the USA [101].
S. uberis is an important causative agent of bovine mastitis worldwide. Although [58] documented the first report of disease outbreak by S. uberis in mandarin fish (Siniperca chuatsi) in China, the first isolation and characterization of this streptococcal species from fish was reported by [119] in Iranian commercial rainbow trout farms. S. uberis was isolated from the gills of healthy fish [126], and thus, the report by Pourgholam et al. [119] is in doubt because they did not assess the pathogenicity of the isolated strains.
S. phocae subsp. salmonis was first isolated from clinical specimens from harbor seal (Phocae vitulina) by Skaar et al. [127] before being isolated from diseased Atlantic salmon cage-farmed in Chile in the summer in 1999, with a reported mortality up to 25% [53,64]. In addition to fish, S. phocae has been recognized as an important pathogen of marine mammals, gray seal (Halichoerus grypus), ringed seal (Phoca hispida), Cape fur seal (Arctocephalus pusillus pusillus), southern sea otters (Enhydra lutris nereis), harbor porpoise (Phocoena phocoena) and other cetaceans, causing pneumonia or respiratory infection [128,129,130,131]. This pathogen has also been associated with urogenital neoplasia in Steller sea lions (Eumatopias jubatus) and skin abscesses in southern sea otters (Enhydra lutris nereis) [132,133], and Taurisano et al. [46] suggested that S. phocae is a serious disease in marine mammals.
Some streptococci species are serious zoonotic pathogens, with S. iniae causing bacteremia, cellulitis, meningitis and osteomyelitis [134], neonatal meningitis, sepsis and pneumonia caused by S. agalactiae [135,136] and bacteremia, lower limb cellulitis and meningitis caused by both S. dysgalactiae subsp. equisimilus and S. dysgalactiae subsp. dysgalactiae [137,138,139,140,141,142]. There are also reports of S. uberis in humans, although the accuracy of this identification is arguable [143]. A problem with streptococcal infections in aquaculture is that, in some outbreaks, the infected fish exhibit no clinical signs prior to death, and the mortalities are mostly due to bacterial septicemia that can involve the brain and nervous system [47,144]. In these cases, the consumption of infected fish, which appear clinically normal, can seriously affect public health.
The immune system of aquatic animals can inevitably be suppressed by various stressors, which increases the animal’s susceptibility to pathogenic agents [47,145]. Stress and stressors, therefore play a significant role in the initiation and development of streptococcal infections. Streptococcal infections are highly stress-dependent and occur in farmed fish exposed to sub-optimal water quality parameters such as sudden fluctuations in temperature or salinity, high alkalinity (pH > 8), low dissolved oxygen concentration and increases in NH3 and NO2. Overfeeding, overstocking and overhandling can also cause outbreaks of streptococcosis with high cumulative mortality [108,146,147,148,149,150]. Mortality caused by streptococcal infections can be reduced by pathogen-free stock/larvae, separate water supplies for culture systems, reducing over-manipulation or transportation, the quarantining of newly arrived fish, reducing overcrowding, avoiding overfeeding, frequently removing dying and dead fish, and keeping excellent sanitary conditions [105]. These preventive precautions can, however, be exceedingly difficult and expensive to implement, as streptococcal agents are quite common in aquatic environments. Due to the formation of granulomatous reactions in different organs of affected fish [151], antibiotic therapy of streptococcal infections is unsuccessful [152]. Treatment by antibiotics may also increase water pollution through frequent drug administration and the release of excess chemical substances into the farm environments, causing further stress of fish. Additionally, frequent antibiotic therapy can increase the withholding period for fish carcasses, and this may interfere with the farm production scheme.

3. Phytotherapy

3.1. Rosemary (Rosmarinus officinalis)

Rosemary contains bioactive compounds, including camphor, a-bisabolol, 1,8-cineole, terpineol-4-ol, a-terpineol and limonene, which possess antibacterial activity [153,154]. Sixteen accessions of rosemary extracted in several solvents were inhibitory towards S. iniae strains, with the ethyl acetate extraction being most efficacious [155]. The ethyl acetate extract was also effective in inhibiting the growth of S. agalactiae strains [156]. The growth of seven strains of S. iniae isolated from diseased rainbow trout was inhibited by the herb's essential oil [157,158], although the efficacy of the ethanolic extract was lower than erythromycin [159], the antibiotic of choice used for the treatment of infection by S. iniae. At concentrations below those which affected bacterial growth (i.e., sub-minimum inhibitory concentrations (sub-MICs), the essential oil decreased the hemolytic activity of S. iniae supernatant and significantly suppressed the transcription of the sagA gene of bacterial isolates [158], suggesting that the essential oil could be useful for the control of S. iniae infection via the inhibition of the production of streptolysin S.
Five days of feeding tilapia (Oreochromis sp.) with powdered rosemary leaves (3:17 w/w, leaf/feed) and ethyl acetate extract (1:24 w/w, extract/feed) significantly increased fish survival following S. iniae challenge (75% survival in treated fish compared to 49% survival in the untreated control) [155]. No significant difference was seen in the survival rate between the ethyl acetate extract and leaf powder treatments or between fish treated with rosemary and fish treated with oxytetracycline (1:199 w/w). Yilmaz et al. [160] fed tilapia (O. mossambicus) for 45 days with 1% rosemary leaves, obtaining a survival rate of 83.37% following challenge with S. iniae, whereas Gültepe et al. [161] found 73% survival with the same feeding regime; the difference in survival between these experiments can be explained by differences in the routes of challenge, bath and intraperitoneal injection. In addition, no significant difference was seen in tilapia survival (56% vs. 56%) following S. iniae challenge when the fish were fed herb leaves at 8% and 16%, but survival rates in both treatment dosages were comparable with oxytetracycline-treated fish (57% survival) and were significantly higher than control fish (35% survival) [156]. Fish fed with 4% leaves, however, exhibited similar survival as the control group [156]. While short feeding (8 days) of the herb leaves at 8% induced no difference in survival in the same species of tilapia challenged with S. agalactiae infection compared to control fish (27% vs. 24%), administration at 16% produced a higher survival rate (38%) [156]. Interestingly, when smaller fish of the same species were administered the herb leaf at either 8 or 16% in feed, treatments were ineffective against S. agalactiae challenge [156]. These data highlight the importance of the optimization of herb dosage and the route and duration of herb administration, as well as fish size. The effectiveness of rosemary against streptococcal infection could be in part due to an enhancement in fish innate and adaptive immune responses, as treated fish have exhibited increased lysozyme phagocytosis and leukocyte counts [161].

3.2. Shirazi Thyme (Zataria multiflora), Garden Thyme (Thymus vulgaris), Avishan-e-Denaii (Thymus daenensis)

Both essential oil and ethanolic extract of Shirazi thyme (Zataria multiflora) were inhibitory towards clinical strains of S. iniae obtained from diseased rainbow trout [157,162], but the essential oil exhibited more inhibitory activity than the extract, according to Soltani et al. [158]. Soltani et al. [158] showed that, when clinical isolates of S. iniae obtained from diseased rainbow trout were exposed to sub-MICs of Shirazi thyme essential oil, a dose-dependent reduction was exhibited in the hemolytic activity of the bacterial supernatant containing streptolysin S, and the transcription of the sagA gene was significantly downregulated in the treated bacterial isolates, suggesting that the essential oil may be used as an alternative to the antibiotic treatment of S. iniae infection. The anti-S. iniae activity of the ethanolic extract of Shirazi thyme was significantly stronger than other tested plants including peppermint (Mentha piperita), savory (Satureja khuzistanica) and chamomile/camomile (Matricaria recutica) and was comparable to erythromycin [159]. The inhibitory effect of Shirazi thyme is probably due to the diversity of the bioactive compounds in the herb [163,164,165], although few data are available to describe the exact mechanism of action.
The essential oil of thyme (Thymus daenensis) was more inhibitory than the ethanolic extract towards S. iniae activity in vitro [166]. The extract of garden thyme (Thymus vulgaris) was inhibitory to S. agalactiae [167], and its essential oil in combination with the essential oils of other plants including oregano (Origanum vulgare) and eucalypts (Eucalyptus spp.) revealed equal MIC and minimum bactericidal concentration (MBC) of 6.25 μL/mL [168], but there was no information on the effectiveness of garden thyme essential oil in isolation.
Mozambique tilapia (O. mossambicus) fry fed with 1.0% garden thyme for 45 days exhibited a significantly higher survival rate than control fish after challenge with S. iniae infection [160]. Similarly, Gültepe et al. [161] obtained a significantly higher survival rate (78%) than control fish (39%) in tilapia fed a diet supplemented with 1.0% garden thyme powder for 45 days and then challenged with S. iniae infection. The inhibitory activity of garden thyme to streptococcal infection could be in part due to citraconic anhydride, 1,8-cineole and thymol. For instance, thymol and citraconic anhydride are well-known antibacterial substances [169,170], through the permeabilization and depolarization of the cytoplasmic membrane of the bacterial cell wall [171]. In addition, the plant may increase the fish immune response, as increased lysozyme and phagocytic activities plus immunocompetent cell population have been detected in treated fish [161].

3.3. Cumin (Cuminum cyminum, Nigella sativa)

Ethanolic extract of black cumin (Nigella sativa) exhibited moderate anti-S. iniae activity in vitro, with equal MIC and MBC values < 2 mg/mL [162]. Seventy-five days feeding Mozambique tilapia with cumin (Cuminum cyminum) as a feed additive at 0.5–2.0% was efficacious against S. iniae infection, providing 62.5–89.5% survival in treated fish vs. 40% survival in control fish. The highest survival achieved in the fish fed 1% cumin, with no adverse side effect on the fish growth [172]. In a subsequent study by Yılmaz et al. [173], 45-day feeding of the same fish species with cumin powder at 1–2% demonstrated a significantly increased resistance (61–86% survival) against S. iniae challenge, while there was no difference in survival between fish fed 0.5% (45%) and control fish (43%). As fish fed with 2% cumin powder had a lower survival (61%) than those fed 1% (86% survival), there appears to be an optimum for the effective control of streptococcosis. Such anti-S. iniae activity by cumin may be in part due to substances such as limonene, α–pinene and 1,8–cineole, as these compounds can improve the antioxidant activity and immune responses [174], although precise details of the mode of action warrant further studies.

3.4. Savory (Satureja bachtiarica, S. khuzistanica, S. montana)

The essential oil of Bakhtiari savory (Satureja bachtiarica) revealed high activity against both S. iniae and S. agalactiae strains, with the lowest MICs of 39 μg/mL and 31.2 µg/mL, respectively [166]. Aqueous extracts of savory (Satureja montana), obtained by the decoction method, however, exhibited moderate antagonistic activity towards S. dysgalactiae species. These findings were supported by the chemical analysis of the savory essential oil, which contained carvacrol (up to 62.3%), thymol (up to 40.6%) and terpinene (up to 28.3%). The ethanolic extract of savory (Satureja khuzistanica) has also been shown to be inhibitory to S. iniae [159].

3.5. Aloe (Aloe vera)

Essential oil of aloe (Aloe vera) exhibited low inhibitory activity against S. iniae strains originally isolated from diseased rainbow trout [175], while the anti-S. iniae effect of its ethanolic extract was comparable with erythromycin [176]. Aqueous and acetone extracts of aloe (Aloe arborescens), however, showed no anti-S. uberis activity [177]. Feeding tilapia (GIFT) with the herb at 0.5 to 2% improved fish immune-physiological variables, including antioxidant and hepatoprotective functions during S. iniae challenge, compared to untreated fish [27], but there was no information on the level of disease resistance in treated fish. One month of the feeding of rainbow trout with the ethanolic extract of aloe (Barbados aloe) at 1% or 1.5% produced a significant increase in disease resistance (>70% survival) with S. iniae challenge, compared to control fish (<50% survival) [39]. The findings were correlated with an enhancement in fish immune responses, including leukocytes, IgM, lysozyme and complement [39]. In a subsequent study by Tafi et al. [176], a ten-day oral therapeutic treatment with the ethanolic extract of aloe at 0.5, 1, and 1.5% in rainbow trout previously challenged with S. iniae demonstrated higher survival (about 67–73%) than control fish (about 50%). No significant differences were seen between aloe-treated fish and fish treated with erythromycin at 80 mg/kg body weight, with no toxic effects for the fish at any concentration of the herb.

3.6. Sage (Salvia officinalis, S. tomentosa, S. verticillate, Phlomis pungens)

The aqueous extract of balsamic sage (Salvia tomentosa) was moderately inhibitory to S. agalactiae [178], but only a weak inhibitory effect was seen with the methanolic extract of this species and the alcoholic extract of lilac sage (S. verticillate) [178]. In addition, the growth of S. agalactiae was inhibited by lilac sage (moderate with alcoholic extract), balsamic sage (weak with water and methanol extracts) and Jerusalem sage (Phlomis pungens) (moderate with water and weak with methanol extract) [178]. One-month feeding with garden sage (S. officinalis) extract at 0.5 to 1.5% in rainbow trout led to increased disease resistance against S. iniae challenge (about 65% survival) at 1.5% and reduced resistance at lower dosages (about 55%), compared to <50% survival in control fish, with this effect possibly be due to the enhancement of fish immune responses, including increased leukocyte population, IgM level, lysozyme and complement activity [39]. The in vitro anti-S. iniae activity of an ethanolic extract of garden sage (Salvia officinalis) was comparable with erythromycin [176], but when rainbow trout intraperitoneally infected with S. iniae were orally treated with 0.5 to 1.5% of the plant extract for ten days, they had only slightly better survival than control fish and significantly lower survival than fish treated with erythromycin (80 mg/kg b.w.).

3.7. Myrtle (Myrtus communis, Rhodomyrtus tomentosa)

The essential oil of myrtle (Myrtus communis) extract revealed relatively high anti-S. iniae activity [166], while a leaf extract of rose myrtle (Rhodomyrtus tomentos) exhibited a strong inhibitory effect against both S. iniae and S. agalactiae, with the lowest MIC of 7.8 μg/mL, much higher than oxytetracycline MIC (0.1 μg/mL) [179]. The plant extract also revealed a dose-dependent bacteriostatic effect towards S. agalactiae. Pre-treatment of S. agalactiae culture with the extract at sub-MIC (0.25 MIC) did not change the susceptibility of bacterial cells to the lysozyme compared to untreated cells, but the pre-treated bacteria were more sensitive to H2O2 exposure; the population of bacteria pre-treated with the extract at 0.25 MIC and 0.125 MIC decreased from 7–8 log10 CFU/ ml to an undetectable level (<2 log10 CFU/mL) within 1–2 h, while untreated cells were able to survive under H2O2 conditions [179]. Further, pre-treatment of S. agalactiae with 0.25 MIC of rose myrtle leaf extract caused a significant reduction in the mortality (10%) of tilapia in an intraperitoneal challenge with the bacterium compared to 45–50% mortality in controls [179].

3.8. Clove Oil (Eucalyptus sp.)

While clove oil (Syzygium aromaticum = Eugenia caryophyllus) was inhibitory against S. agalactiae [167], its extract showed no inhibition activity [180]. Both 100% pure clove essential oil (Aromarant Co. Ltd., Rottingen, Germany) purified from the buds and commercial eugenol (>99%) (Tokyo Chemical Industry Co. Ltd., Tokyo, Japan) were inhibitory to the growth of S. iniae and S. parauberis [181] A comparison of the MBC/MIC ratios of eugenol (1:4) and clove essential oil (1:2) towards S. iniae isolates indicates a greater bactericidal tendency from clove essential oil, whereas eugenol had more bacteriostatic activity at lower concentrations [181]. These in vitro data clearly show that clove contains diverse bioactive substances with different abilities to inhibit the growth and multiplication of S. iniae.
The use of nano-emulsions of essential oils obtained from Tasmanian blue gum (Eucalyptus globulus) demonstrated ameliorating inhibitory activity against S. iniae compared to their essential oil counterparts [182], suggesting a better antibacterial function from the nano-emulsion of the herb.

3.9. Lavender (Lavendula angustifolia)

Lavender (Lavendular angustifolia) essential oil was shown to be a promising inhibitor against isolates of S. iniae and S. parauberis, mainly due to bacteriostatic activity [183]. One strain of S. parauberis was most sensitive, with MIC of 0.063% and an MIC:MBC ratio of 1:8, indicating the possibility of bacterial survival at high concentrations of lavender essential oil, although it is not able to grow at very low concentrations. The nano-emulsion oil of lavender demonstrated greater inhibitory activity than its essential oil counterpart [182], suggesting a better antibacterial function from the nano-emulsion of the plant. The mode of action of lavender oil, however, warrants further study.

3.10. Moshkoorak (Oliveria decumbens)

Essential oil, ethanolic extract and aromatic water of Moshkoorak (Oliveria decumbens) revealed inhibition against S. iniae, with the lowest and the highest MICs measured for the essential oil and aromatic water compounds, respectively [40]. Nile tilapias were orally treated with either the ethanolic extract or essential oil for 60 days at 0.01% exhibited similar survival (57%) following challenge with S. iniae, while the use of aromatic water at 0.125% or a combination of aromatic water and essential oil at 0.1% revealed slightly higher survival (64.28%). The survival rates of all treated fish were, however, higher than control fish. The antibacterial activity of this plant could be due to the high concentration (up to 52%) of bioactive substances such as carvacrol [40].

3.11. Garlic (Allium sativum)

The ethanolic extract of garlic (Allium sativum) was strongly inhibitory towards S. iniae and S. agalactiae strains [42,167], and the two-week feeding of Nile tilapia (O. niloticus) with garlic powder at 0.5 g and 1 g/100 g diet revealed significantly higher survival (54% at 0.5 g inclusion and 84% at 1.0 g inclusion) than control fish (10%) following a challenge infection with S. iniae [42]. The increased survival of garlic-treated fish that was in part due to the enhancement in fish immune responses (e.g., upregulation of IL-10 and IL-17 genes) reported by the authors. Such a positive correlation between in vitro antibacterial activity and in vivo disease resistance is promising, but the bioavailability of the garlic bioactive compounds in the fish tissues/serum merits further research to standardize the optimum dosage for the treatment of S. iniae infection.

3.12. Cinnamon (Cinnamomum spp.)

The ethanolic extract of Indian bay leaf (Cinnamomum tamala) was inhibitory to S. iniae strains [42], and the extract of cinnamon (Cinnamomum verum) showed high anti-S. agalactiae activity [167] that could be due to aromatic substances in the herbs. In addition, eight isolates of S. uberis were sensitive to both the essential oil and aqueous extract of cinnamon (Cinnamomum cassia), possibly due to the presence of compounds such as cinnamaldehyde, eugenol, cinnamic acid, witherhin, mucilage and diterpenes [184].
The seven-day feeding of tilapia with extract and powder of cinnamon (C. verum) showed 60% and 68.7% survival, respectively, in a S. agalactiae challenge [167]. No significant difference in survival rate was seen between treated fish and fish treated with oxytetracycline, suggesting that cinnamon may be a promising prophylactic tool against tilapia streptococcosis. In addition, the three-month feeding of tilapia with methanol extract of camphor (Cinnamomum camphora) revealed significantly higher survival (80%) against S. agalactiae infection than control fish (56.7% survival) [185].

3.13. Milletia Dielsiana (Spatholobus suberectus)

There are very scarce data on the efficacy of medicinal plants in combination with antibiotics against streptococcal infections in fish. A combination of extract of Milletia dielsiana (Spatholobus suberectus) and streptomycin sulfate displayed antibacterial synergism against S. agalactiae in an agar well diffusion assay [186]. Nile tilapia fed 0.52% the herb extract in combination with 0.013% streptomycin sulfate exhibited 80.5% relative survival compared to 52.6% in fish fed the extract alone, again indicating a synergistic effect of the herb and antibiotic for the treatment of S. alaglactiae infection in fish.

3.14. Allspice (Pimenta dioica)

A-50-day oral administration of various dosages of allspice (Pimenta dioica) to Mozambique tilapia fry revealed that the use of allspice at 10 g/kg feed not only provided the best growth performance but also the highest protection (80% survival compared to 38% in control fish) against S. iniae challenge [30]. Allspice is currently used in traditional folklore medicine [187], and its protective functions thought to be due to various bioactive substances including flavonoids, phenolic acids, catechins and several phenylpropanoids [188], as well as eugenol, cineol, phellandrene, caryophyllene and pimentol [189], which have both antibacterial activity and immune-enhancer properties [187].

3.15. Ginger (Zingiber officinale, Tetradenia riparia)

Water and acetone extract preparations of ginger bush (Tetradenia riparia) exhibited inhibitory effects against S. uberis, with a best index value of 4.22 [177]. The dietary supplementation of ginger (Zingiber officinale) at 1% to olive flounder for 8 weeks demonstrated a significantly higher survival rate following S. inae infection (66.7% survival) compared to control fish (5% survival) [41]. This improvement might be in part due to the enhancement of the immune responses of the treated fish. However, despite an immunostimulatory effect shown by Brum et al. [38], feeding essential oil of the herb at 0.5% to 1.5% to Nile tilapia for 55 days found no significant difference in survival between treated fish and control fish when challenged with S. agalactiae [38].

3.16. Oregano (Origanum vulgare)

The nano-emulsion of the essential oil of oregano (Origanum vulgare) demonstrated improved inhibitory activity against S. iniae compared to the essential oil counterpart [182], suggesting a better antibacterial function by the nano-emulsion of the herb. The MIC of the nano-emulsion was also lower than the tetracycline MIC. Such anti-S. iniae activity could be in part due to carvacrol, a monoterpenic phenol, one the major antibacterial compounds found in oregano.

3.17. Pomegranate (Punica granatum)

Using disk diffusion or micro-dilution methods, an ethanol extract of pomegranate (Punica granatum) revealed a relatively high anti-S. iniae activity, according to Ghasemi Pirbalouti et al. [166], while both aqueous and methanol extracts exhibited antagonistic activity towards S. uberis isolates with identical MIC and MBC values [190].

3.18. Isothiocyanates in Cruciferous Vegetables

All ten isothiocyanates (ITCs) present in cruciferous vegetables were inhibitory against S. iniae and S. parauberis strains isolated from olive flounder, but with different MIC and MBC values; the lowest MIC was measured for sulforaphane [191], and S. paraurberis was more susceptible to these ITCs than S. iniae [191].

3.19. Algae

The methanolic extract of marine brown alga (Ecklonia cava) and its ethyl acetate soluble fractions were better inhibitors than the E. stolonifera extract towards S. iniae and S. parauberis strains [192]. This could be due to phlorotannin compounds such as dieckol, which was found in the ethyl acetate soluble fraction of E. cava by Kim et al. [192], although Eom et al. [193] showed that the n-hexane soluble fraction of the extract showed the highest anti-S. parauberis activity, with MICs ranging from 256 to 1024 μg/mL [193]. Interestingly, the use of a combination of the hexane fraction with oxytetracycline exhibited a significant reduction up to 64-fold in the MIC value against S. parauberis isolates, suggesting a synergistic antibacterial activity.

3.20. Miscellaneous Plants

3.20.1. In Vitro Anti-S. iniae and Anti-S. parauberis Bioassays

Ethanolic extracts of skullcaps (Scutellaria radix) and olive (Olea europaea) exhibited equal anti-S. iniae activity [162], and an ethanolic extract of chamomile/camomile (Matricaria recutica) was more active than peppermint (Mentha piperita) [159], probably due to differences in bioactive substances [163,164,165]. Ethanol extracts of oak (Quercus branti) and liquorice (Glycyrrhiza glabra) and essential oils of hogweed (Heracleum lasiopetalum), tarhana herb (Echinophora platyloba), celeriac (Kelussia odoratissima) and lolopashmak (Stachys lavandulifolia) exhibited anti-S. iniae activity, although the essential oil of tarhana herb and the ethanol extract of oak showed the highest inhibitory activity [166]. The essential oil of pennyroyal (Mentha pulegium) was inhibitory against several clinical isolates of S. iniae recovered from diseased rainbow trout [175]. All aqueous, ethanolic and methanolic extracts of both neem (Azadirachta sp.) leaves and turmeric rhizome (Curcuma longa) were effective against S. iniae with an identical MIC of 1000 μg/mL that could be due to bioactive ingredients such as saponins, tannins, flavonoids and polysterols, which are present in both herbs [194]. Ethanolic extracts of the leaves of amla (Phyllanthus emblica), bohera leaves (Terminalia bellirica) and arjun (Arjun coomaraswamy) were inhibitory to S. iniae strains [42]. Skin mucus sampled from rainbow trout fed ethanol extract of stinging nettle (Urtica dioica) at 3% supplementation for 8 weeks showed enhanced antagonistic activity against S. iniae compared to mucus from control fish [195]. In a subsequent study, skin mucus from koi carp (Cyprinus carpio koi) fed ferula (Ferula asafo etida) powder at 20 and 25 g/kg in the diet for nine weeks exhibited anti-S. iniae activity [196]. In both studies, the immune responses of treated fish were enhanced, resulting in improved disease resistance to streptococcosis. Sera samples of rainbow trout intraperitoneally administered safflower (Carthamus tinctorius) ethanolic extract (100 mg/kg body weight) significantly increased anti-S. iniae activity compared to control fish [197], but no anti-S. iniae activity was seen in the sera of fish treated with a higher dosage (200 mg/kg body weight). Among forty natural Korean plants assessed by Kang et al. [198], only the extractions of nine inhibited the growth of S. iniae and S. parauberis strains, with the strongest inhibition with extracts of Jipsinnamul (Agrimonia pilosa), Dokhwal (Aralia cordat), N, Nadosongipul (Phtheirospermum japonicum), and Sumbadi (Dystaenia takesimana) providing the greatest anti-S. parauberis activity. Ethanolic extract of Korean blackberry (Rubus coreanus) inhibited the growth of S. iniae and S. parauberis at various concentrations (12.5–100 g/mL), with the extent of inhibition being dose-dependent [199]. The authors demonstrated that the extract was rich in phenolic compounds (48.36 ± 0.39 mg gallic acid equivalent/g), with a wide range of antibacterial activity against both Gram-positive and Gram-negative bacterial pathogens of fish. The essential oil of lemongrass (Cymbopogon flexuosus) exhibited strong activity against S. iniae and S. parauberis strains [200], and, based on the MBC/MIC ratio (<4), the essential oil was bactericidal for most of the tested strains. Essential oils of leaves of Manchurian fir (Abies holophylla), Japanese black pine (Pinus thunbergii), southern Japanese hemlock (Tsuga sieboldii), and pitch × loblolly hybrid pine (Pinus rigitaeda) exhibited activity against S. parauberis, with Japanese black pine and southern Japanese hemlock oils showing the highest and the lowest actively, respectively [201].

3.20.2. In Vivo Anti-S. iniae Bioassay

Mozambique tilapia fed fenugreek (Trigonella foenum graecum) for 45 days exhibited 69% survival against S. iniae challenge, compared to 39% survival in control fish [161]. A three-month feeding trial of the same fish species with essential oil of sweet orange peel (Citrus sinensis) at 0.1 to 0.5% induced 46.67 to 58.33% survival compared to 13.3% in control fish, probably due to an enhancement of fish immune-physiological functions [37]. In a later study by Apraku et al. [202], Nile tilapia fed virgin coconut oil at various concentrations (0.75% to 3%) for eight weeks had significantly improved protection against S. iniae challenge compared to control fish. This may have been due in part to monoglycerides, lauric acid and monolaurin, which have been identified as components of coconut oil with antibacterial and immunostimulatory effects [203].
Eight-week dietary supplementation of yacon (Smallanthus sonchifolius) and blueberry (Cyanococcus) each at 1% to olive flounder resulted in significantly higher disease resistance, 66.7–76.7% survival, respectively, against S. iniae infection, compared to 5% survival in control fish [41], but the mode of action of this protection requires further study. The two-month feeding of rainbow trout with ethanolic extract of purple coneflower (Echinacea purpurea) (0.5, 1 and 1.5 g/kg diet) revealed higher survival compared to control fish only in fish fed a 1.5 g/kg diet, after challenge with S. iniae infection [204]. The addition of water hyacinth (Eichhornia crassipes) to the rainbow trout diets significantly enhanced fish survival following S. iniae infection, with the highest survival obtained in fish fed 1% of the plant [205]. Such protection may be in part due to diverse bioactive substances (e.g., phenolic compounds polyphenols and flavonoids) in water hyacinth that can stimulate fish immunity [205,206,207,208].

3.20.3. In Vitro Anti-S. agalactiae Bioassay

Five flavonoids (morin, morin-3-O-lyxoside, morin-3-O-arabinoside, quercetin, and quercetin-3-O-arabinoside) obtained from lemon guava (Psidium guajava) leaves were inhibitory towards S. agalactiae strains, but with different degrees of inhibitory activity [209]. This suggests that leaves of lemon guava may be a candidate for treating S. agalactiae infection, but in vivo studies need to confirm this. The aqueous extract of green chiretta (Andrographis paniculate) displayed anti-S. agalactiae activity and feeding leaf powder or dried aqueous extract to tilapia decreased fish mortality after challenge with S. agalactiae [210].
Various extracts from aerial (leaf- stem), flower and root parts of six species of poppy plants (Papaver) including P. macrostomum, P. dubium, P. argemone, P. bracteatum, P. armeniacus microstigma and P. chelidonium folium exhibited anti-S. agalactiae effects, with ethanolic and methanolic extracts having greater efficacy than aqueous extracts [211]. Among these plants, P. argemone showed the highest inhibitory effect, followed by the root, aerial parts and flowers of P. chelidonium folium. In addition, the results revealed that the isokinolin alkaloids of the examined plants possessed an antimicrobial effect [211]. The ethanolic extract of leaves of Madeira vines (Anredera diffusa) was inhibitory to S. agalactiae strains [211], and among alcoholic and aqueous extracts from 22 species of Turkish plants, the strongest anti-S. agalactiae activity was obtained with an ethanolic extract of everlasting (Helichrysum plicatum) [178]. Furthermore, extracts of yellow waterlily (Nuphar lutea) with various solvents and the ethanolic extract of lydian broom (Genista lydia) displayed a moderate anti-S. agalactiae activity, but only a weak inhibitory effect was seen with extracts of European white-water lily (Nymphaea alba) [178].
Ethanolic extracts of orange cestrum (Cestrum auriculatum), rhatany (Krameria triandra) and sauco (Sambucus peruviana) [212], both aqueous and alcoholic extracts of roselle (Hibiscus sabdariffa Linn) and alcoholic extracts of koon (Cassia fistula Linn) and banana (Musca saientum Linn) inhibited the growth of S. agalactiae strains [213]. Roselle was superior to the other plants in terms of toxicity and residual effects, and the alcoholic extracts of roselle were more efficacious than the aqueous extract. Aqueous and methanolic extracts of kulikhara (Asteracantha longifolia), crowfoot grass (Dactyloctenium indicum) and Indian borage (Trichodesma indicum) were inhibitory to S. agalactiae, with methanolic extractions showing a better inhibition [214].
Among black pepper (Piper nigrum), curry leaf (Murraya koenigii), onion (Allium cepa) and Vietnamese coriander (Persicaria odorata), a methanolic extract of curry leaf was the most inhibitory towards S. agalactiae strains [180]. Aqueous extracts of drumstick tree (Moringa oleifera) were more inhibitory towards S. agalactiae biotype II than garden apple (Aegle marmelos) [215]. Chloroform-extracted compounds of Chinese mahogany (Toona sinenses) also exhibited activity against biotype II, while the ethanolic extract of the neem (margosa) tree (Azadirachta indica) showed moderate inhibitory activity [215], and the authors suggested drumstick tree leaves as a potential source of anti-streptococcal agents [215].

3.20.4. In Vivo Anti-S. agalactiae Bioassay

The oral use of the aqueous extract of mampat (Cratoxylum formosum) at 0.5–1.5% in feed enhanced the innate immune responses of tilapia and significantly increased the survival (44–90%) of fish against S. agalactiae challenge compared to control fish (18%), with significantly higher survival at higher dosages [216]. Tilapia fed various levels (0.025–0.4%) of shrubby sophora (Sophora flavescens) exhibited survival rates of 47.8 to 79.9% compared to about 20% survival in control fish after challenge with S. agalactiae [217]. Higher survival was seen at 0.1% feed levels, due in part to enhanced immune responses including lysozyme, complement and respiratory burst measured in fish fed shrubby sophora at this level [217]. Tilapia fed papaya (Carica papaya) seed and asthma weed (Euphorbia hirta) exhibited 70% survival against S. agalactiae challenge [185]. The four-week feeding of Nile tilapia with the ethanolic extract of milky mangrove (Excoecaria agallocha) leaf at 20–50 mg/kg in the diet led to a significantly higher survival rate (40–63%) after challenge with S. agalactiae compared to control fish (3% survival) [6]. Greater survival was obtained at higher dosages and was correlated with enhanced fish immune responses (immunocompetent cell population, and lysozyme, respiratory burst, phagocytosis and serum bactericidal activities).
Eight weeks of feeding tilapia with an extract of Assam tea (Camellia sinensis) induced an enhancement in fish immune responses (lysozyme, peroxidase, alternative complement, phagocytosis and respiratory burst) and increased disease resistance against S. agalactiae challenge [218]. Assam tea contains bioactive compounds, including flavanonones, phenolic acids, catechins and flavonols, that can enhance animal immunity [219,220,221,222]. The four-week feeding of Nile tilapia with a mixture of traditional Chinese herbs consisting of hawthorn (Crataegus hupehensis), dong quai (Angelica sinensis, and Mongolian milkvetch (Astragalus membranaceus) at equal ratios produced 70% survival vs. 35% survival in control fish following challenge with S. agalactiae, possibly due to enhancement in immune responses (lysozyme, superoxide dismutase, catalase, heat shock protein 70 and IgM) [223]. Among the aqueous extracts of ten Chinese herbal medicines fed to Nile tilapia, Dutchman’s pipe (Aristolochia debilis) (fruit) and Chinese ginseng (Panax ginseng) (leaf) exhibited the highest therapeutic efficacy (calculated based on the effective concentration in RPS of 50%) in a S. agalactiae challenge [224].

3.20.5. In Vitro Anti-S. dysgalactiae Bioassay

Plant-derived compounds including thymol, carvacrol, eugenol and trans-cinnamaldehyde were inhibitory towards S. dysgalactiae, with the strongest inhibition shown by trans-cinnamaldehyde [225]. The ethanolic extracts of common purslane (Portulaca oleracea) and common dandelion (Taraxacum mongolicum) exhibited higher inhibition of S. dysagalactiae strains than the aqueous extracts of the same plants [226]. Methanolic extracts of ashwagandha/winter cherry (Withania somnifera), colocynth/bitter (Citrullus colocynthis) and black pepper (Piper nigrum) at various concentrations inhibited the growth of S. dysgalactiae strains, with the level of activity being dose-dependent [227]. The inhibitory activity of ashwagandha and colocynth was similar and higher than that of black pepper. It has been shown that the solubility and bioactivity of plant-derived chemical compounds are largely dependent on the method of extraction, with decoction being one of the most effective methods for the extraction of bioactive compounds [228]. When S. dysgalactiae was challenged with billygoat weed (Ageratum conyzoides), betel (Piper betle) and turmeric (Curcuma domestica), all herbs inhibited growth of the bacterium even at high bacterial concentrations [229].

3.20.6. In Vitro Anti-S. uberis Bioassays

There are fewer data available for phototherapeutic efficacy towards S. uberis than for other streptococcal species in fish. As S. uberis is a zoonotic pathogen, the in vitro data discussed here are for isolates recovered from terrestrial animals. Four plant-derived compounds, including trans-cinnamaldehyde (TC), eugenol, carvacrol and thymol, were inhibitory to S. uberis isolates, with TC exhibiting better inhibition than the others [225]. Bioactive substances obtained by supercritical fluid extraction with carbon dioxide from lichen (Usnea barbata) exhibited stronger anti-S. uberis activity than ethanolic extracts [230]. The extract with a lower usnic acid level was most inhibitory and was also more effective against S. uberis than ampicillin, erythromycin and penicillin [230]. Both peperina (Minthostachys verticillate) essential oil and limonene were antagonistic to S. uberis strains, with limonene having a lower MIC value [231]. The aqueous and acetone extracts of thorny acacia (Acacia nilotica) leaves [232] and fairy crassula (Crassula multicava) [177] were inhibitory to S. uberis strains. The inhibitory activity of thorny acacia was dose-dependent and could be in part due to the bioactive compounds, including the carbohydrates, glycosides, phytosterols, phenols, saponins and flavonoids that are major constituents of this plant [232].
Table 1. In vitro inhibitory activity of medicinal/plants to S. iniae.
Table 1. In vitro inhibitory activity of medicinal/plants to S. iniae.
Bacterial Origin/SourceMedicinal Herb/PlantExtraction/Essence MethodInhibitory MethodMIC or Zone of InhibitionMBCTemp
(°C)
Ref.
TilapiaRosmarinus officinalisMethanolic extractDisk diffusion4.3–17.1 mm/mgUnknown25[155]
TilapiaRosmarinus officinalisEthanolic extractDisk diffusion5.7–19.7 mm/mgUnknown25[155]
TilapiaRosmarinus officinalisMethanol/ethyl acetate (1:1)Disk diffusion3.1–23.8 mm/mgUnknown25[155]
TilapiaRosmarinus officinalisEthyl acetateDisk diffusion9.38–37.5 m/mgUnknown25[155]
Rainbow troutRosmarinus officinalisEssential oilMicrodilution0.12–0.25 µL/mL0.5–1.0 µL/mL25[157]
Rainbow troutEucalyptus camaldulensisEssential oilMicrodilution160–320 µL/mL>320 µL/mL25[175]
Rainbow troutMentha pulegiumEssential oilMicrodilution40–320 µL/mL>320 µL/mL25[175]
Rainbow troutAloe veraEssential oilMicrodilution>320 µL/mL>640 µL/mL25[175]
Rainbow troutZataria multifloraEssential oilMicrodilution0.06 µL/mL0.12–0.5 µL/mL25[157]
Rainbow troutZataria multifloraEthanolic extractMicrodilution0.125 mg/mLUnknownUnknown[162]
Rainbow troutPunica granatumEthanolic extractMicrodilution0.125 mg/mLUnknownUnknown[162]
Rainbow troutNigella sativaEthanolic extractMicrodilution<2 mg/mL<2 mg/mLUnknown[162]
Rainbow troutScutellaria radixEthanolic extractMicrodilution<2 mg/mL<2 mg/mLUnknown[162]
Rainbow troutOlea europaeaEthanolic extractMicrodilution<2 mg/mL<2 mg/mLUnknown[162]
S. iniae KCTC 3657Agrimonia pilosaWater extractDisk diffusion29–34 mm (1000 ppm)Unknown25[198]
S. iniae KCTC 3657Aralia cordatWater extractDisk diffusion9–14 mm (3000 ppm)Unknown25[198]
S. iniae KCTC 3657Quercus mongolicaWater extractDisk diffusion9–14 mmUnknown25[198]
S. iniae KCTC 3657Phtheirospermum japonicumWater extractDisk diffusion9–14 mm (4000 ppm)Unknown25[198]
S. iniae KCTC 3657Geranium wilfordiWater extractDisk diffusion9–14 mmUnknown25[198]
S. iniae KCTC 3657Carpinus laxifloraWater extractDisk diffusion9–14 mmUnknown25[198]
S. iniae KCTC 3657Sedum takesimensWater extractDisk diffusion9–14 mmUnknown25[198]
S. iniae KCTC 3657Dystaenia takesimanaWater extractDisk diffusion24–29 mm (3000 ppm)Unknown25[198]
Marine fishRubus coreanusEthanolic extractDisk diffusion7.2 ± 0.07 mm (100 µg/mL)Unknown35–37[199]
Rainbow troutPunica granatum (flower)Ethanolic extractMicrodilution>1000 μg/mLUnknown37[166]
Rainbow troutQuercus branti (seed)Ethanolic extractMicrodilution625 μg/mLUnknown37[166]
Rainbow troutGlycyrrhiza glabra (root)Ethanolic extractMicrodilution>1000 μg/mLUnknown37[166]
Rainbow troutHeracleum lasiopetalum (fruit)Essential oilMicrodilution78 μg/mLUnknown37[166]
Rainbow troutSatureja bachtiarica (aerial)Essential oilMicrodilution39 μg/mLUnknown37[166]
Rainbow troutThymus daenensis (aerial plant)Essential oilMicrodilution312 μg/mLUnknown37[166]
Rainbow troutMyrtus communis (leaf)Essential oilMicrodilution>1000 μg/mLUnknown37[166]
Rainbow troutEchinophora platyloba (aerial)Essential oilMicrodilution312 μg/mLUnknown37[166]
Rainbow troutKelussia odoratissima (leaf)Essential oilMicrodilution>1000 μg/mLUnknown37[166]
Rainbow troutStachys lavandulifolia (flower)Ethanolic extractMicrodilution>1000 μg/mLUnknown37[166]
Rainbow troutRosmarinus officinalisEssential oilMicrodilution0.06 μL/mL0.5 μL/mL25[158]
Olive flounderCruciferous vegetablesSulforaphaneMicrodilution0.09 ± 0.03 mg/mL0.28 ± 0.15 mg/mL37[191]
Olive flounderCruciferous vegetablesSulforaphaneMicrodilution0.25 mg/mL1 mg/mL37[191]
Olive flounderCruciferous vegetablesIberinMicrodilution0.25 mg/mL1 mg/mL37[191]
Olive flounderCruciferous vegetablesErucin isothiocyanatesMicrodilution0.09 ± 0.03 mg/mL0.5 ± 0.3 mg/mL37[191]
Olive flounderCruciferous vegetablesAllyl isothiocyanatesMicrodilution>4 mg/mL>4 mg/mL37[191]
Olive flounderCruciferous vegetablesHexyl isothiocyanatesMicrodilution4 mg/mL>4 mg/mL37[191]
Olive flounderCruciferous vegetablesPhenylethyl isothiocyanatesMicrodilution0.625 ± 0.25 mg/mL1.125 ± 0.629 mg/mL37[191]
Olive flounderCruciferous vegetablesBenzyl isothiocyanatesMicrodilution0.219 ± 0.06 mg/mL0.25 mg/mL37[191]
Olive flounderCruciferous vegetablesPhenyl isothiocyanatesMicrodilution2 mg/mL>4 mg/mL37[191]
Olive flounderCruciferous vegetablesIndole-3-carbinolMicrodilution0.125 mg/mL0.25 mg/mL37[191]
Olive flounderRadish rootHydrolysate of radish rootMicrodilution0.25 mg/mL0.25 mg/mL37[191]
Marine fishEcklonia cavaMethanolic extractDisk diffusion14.5 mmUnknownUnknown[192]
Marine fishEcklonia cavaButanol fractionDisk diffusion7 mmUnknownUnknown[192]
Marine fishEcklonia cavaWater fractionDisk diffusion10 mmUnknownUnknown[192]
Marine fishEcklonia cavaEthyl acetate soluble fractionMicrodilution256 μL/mLUnknownUnknown[192]
Marine fishEcklonia stoloniferaMethanolic extractDisk diffusion11 mmUnknownUnknown[192]
Rainbow troutZataria multifloraEssential oilMicrodilution0.12 μL/mL0.25 μL/mL25[158]
TilapiaRhodomyrtus tomentosEthanolic extractMicrodilution7.8 μg/mL 15.2–31.2 μg/mL 37[179]
S. iniae ATCC2917Urtica dioicaEthanolic extractMicrodilution200 μg/mL Unknown37[195]
Unknown Carthamus tinctoriusEthanolic extractMicrodilutionBactericidal effect Unknown37[197]
African catfishAzadirachta indica leafAqueous extractWell diffusion25 mmUnknown37[194]
African catfishAzadirachta indica leafEthanolic extractWell diffusion25 mmUnknown37[194]
African catfishAzadirachta indica leafMethanolic extractWell diffusion15 mmUnknown37[194]
African catfishTurmeric rhizome Aqueous extractWell diffusion25 mmUnknown37[194]
African catfishTurmeric rhizome Ethanolic extractWell diffusion15 mm Unknown37[194]
African catfishTurmeric rhizome Methanolic extractWell diffusion20 mmUnknown37[194]
African catfishAzadirachta indica leafMethanolic extractMicrodilution1000 μg/mLUnknown37[194]
African catfishTurmeric rhizome Methanolic extractMicrodilution1000 μg/mLUnknown37[194]
Marine fishOriganum vulgareEssential oilMicrodilution25 μg/mL25 μg/mL24[182]
Marine fishEucalyptus globulusEssential oilMicrodilution100 μg/mL100 μg/mL24[182]
Marine fishMelaleuca alternifoliaEssential oilMicrodilution100 μg/mL100 μg/mL24[182]
Marine fishLavendula angustifoliaEssential oilMicrodilution100 μg/mL100 μg/mL24[182]
Marine fishOriganum vulgareNano-emulsion of essential oilMicrodilution12.5 μg/mL12.5 μg/mL24[182]
Marine fishEucalyptus globulusNano-emulsion of essential oilMicrodilution100 μg/mL100 μg/mL24[182]
Marine fishMelaleuca alternifoliaNano-emulsion of essential oilMicrodilution50 μg/mL50 μg/mL24[182]
Marine fishLavendular angustifoliaNano-emulsion of essential oilMicrodilution100 μg/mL100 μg/mL24[182]
Olive flounderLavendular angustifoliaessential oilMicrodilution0.06–0.12% (v/v)0.5–4.0% (v/v)27[183]
Olive flounderSyzygium aromaticumessential oilMicrodilution0.25–0.5% v/v0.25–1% v/v27[181]
Olive flounderSyzygium aromaticumEugenolMicrodilution0.125–0.5% v/v0.5–1% v/v27[181]
Unknown Oliveria decumbensEthanolic extractMicrodilution18.75 mg/mL75 mg/mL25[40]
Unknown Oliveria decumbensEssential oilMicrodilution0.5 mg/mL2 mg/mL25[40]
Unknown Oliveria decumbensAromatic waterMicrodilution4 mg/mL16 mg/mL25[40]
TilapiaAllium sativumEthanolic extractDisk diffusion 13 mmUnknownUnknown[42]
TilapiaPhyllanthus emblicaEthanolic extractDisk diffusion9 mmUnknownUnknown[42]
TilapiaTerminalia belliricaEthanolic extractDisk diffusion7 mmUnknownUnknown[42]
TilapiaSyzygium aromaticumEthanolic extractDisk diffusion7 mmUnknownUnknown[42]
TilapiaArjun coomaraswamyEthanolic extractDisk diffusion7 mmUnknownUnknown[42]
TilapiaCinnamomum tamalaEthanolic extractDisk diffusion7 mmUnknownUnknown[42]
S. iniae ATCC29178Ferula asafoetidaPowderDisk diffusion9 mmUnknown37[196]
Olive flounderCymbopogon flexuosusEssential oil Microdilution0.03–0.12% (v/v)0.125–0.5% v/v27[200]
UnknownMentha piperitaEthanolic extractDisk diffusion18.5 mg/mL18.5 mg/mL37[159]
UnknownSatureja khuzistanicaEthanolic extractDisk diffusion10.8 mg/mL10.8 mg/mL37[159]
UnknownMatricaria recuticaEthanolic extractDisk diffusion8.2 mg/mL16.5 mg/mL37[159]
UnknownZataria multifloraEthanolic extractDisk diffusion4.8 mg/mL9.7 mg/mL37[159]
UnknownRosmarinus officinalisEthanolic extractDisk diffusion16.8 mg/mL33.6 mg/mL37[159]
S. inaie BCG/LMG 3740Aloe veraEssential oilDisk diffusion4.06 mg/mL4.06 mg/mL37[159]
S. inaie BCG/LMG 3740Salvia officinalisEthanolic extractDisk diffusion2.59 mg/mL5.18 mg/mL37[139]
Table 2. In vivo disease resistance of medicinal/plants to S. iniae infection. IP = intraperitoneal injection, IM = intramuscular injection.
Table 2. In vivo disease resistance of medicinal/plants to S. iniae infection. IP = intraperitoneal injection, IM = intramuscular injection.
Medicinal Herb/PlantExtraction MethodFish SpeciesDosage and DurationWater Temp. (°C)Challenge RouteSurvival Rate (%)Ref.
Rosmarinus officinalisLeavesTilapia3:17 w/w (leaf/feed), 5 days26 ± 1IP75[155]
Rosmarinus officinalisEthyl acetate extractTilapia1:24 w/w (extract/feed), 5 days26 ± 1IP80[155]
Rosmarinus officinalisLeavesTilapia4%, 5 days26 ± 1IP35 [156]
Rosmarinus officinalisLeavesTilapia8%, 5 days26 ± 1IP56 [156]
Rosmarinus officinalisLeavesTilapia16%, 5 days26 ± 1IP50[156]
Cuminum cyminumSeed mealTilapia0.5–2% feed, 75 days28.6 ± 0.1Bath62.5–89.5[21]
Trigonella foenum graecumPowderTilapia1% in feed, 45 days28.4 ± 0.1Bath84.72[160]
Thymus vulgarisPowderTilapia1% in feed, 45 days28.4 ± 0.1Bath86.11[160]
Rosmarinus officinalisPowderTilapia1% in feed, 45 days28.4 ± 0.1Bath83.37[160]
Cuminum cyminumSeed mealTilapia1–2% in feed, 45 days28.3 ± 0.1Bath61–84[173]
Thymus vulgarisPowderTilapia1% in feed, 45 days28.4 ± 0.6IP78[161]
Rosmarinus officinalisPowderTilapia1% in feed, 45 days28.4 ± 0.6IP73[161]
Trigonella foenum graecumPowderTilapia1% in feed, 45 days28.4 ± 0.6IP69[161]
Pimenta dioicaSeed meal powderTilapia5, 10, 15, 20 g/kg feed, 50 days28.4 ± 0.7Bath49–80%[30]
Citrus sinensisEssential oilTilapia0.1%, 0.3%, 0.5%, 90 days28Bath46.7–58.3[37]
Virgin coconut oilCoconut oilTilapia3% in feed, 8 weeks28–29IPabout 73 [48]
Virgin coconut oilCoconut oilTilapia0.75% in feed, 8 weeks28–29IPabout 60[48]
Virgin coconut oilCoconut oilTilapia1.5% in feed, 8 weeks28–29IPabout 67 [48]
Virgin coconut oilCoconut oilTilapia2.25% in feed, 8 weeks28–29IPabout 54[48]
Aloe vera (Barbados aloe)Ethanolic extractRainbow trout1%, 1.5%, 30 days14 ± 1IP76[39]
Salvia officinalis (Sage) Ethanolic extractRainbow trout 1.5%, 30 days14 ± 1IP65[39]
Yacon (Smallanthus sonchifolius)PowderOlive flounder1%, 56 days18 ± 3IP76.7[41]
Ginger Zingiber officinalePowderOlive flounder1%, 56 days18 ± 3IP66.7[41]
Blueberry (Cyanococcus)PowderOlive flounder1%, 56 days18 ± 3IP85[41]
Oliveria decumbensEssential oil Tilapia0.01%, 60 daysUnknownOral57[40]
Oliveria decumbensEthanolic extractTilapia0.01%, 60 daysUnknownOral57.14[40]
Oliveria decumbensAromatic waterTilapia0.125%, 60 daysUnknownOral64.28[40]
Oliveria decumbensExtract + essential oilTilapia0.1%, 60 daysUnknownOral64.28[40]
Allium sativumEthanolic extractTilapia0.5 g/100 g feed, UnknownIM~54[42]
Allium sativumEthanolic extractTilapia1 g/100 g feed, UnknownIM~84[42]
Eichhornia crassipesAqueous extractRainbow trout 0.25, 0.5, 1% in feed, 56 days15 ± 1.1IP21.8 ± 6.5–34.7 ± 14.3[205]
Eichhornia crassipesMethanolic extractRainbow trout 0.25, 0.5, 1%, in feed, 56 days15 ± 1.1IP24.8 ± 7.3–49.6 ± 4.7[205]
Salvia officinalisEthanolic extractRainbow trout 0.5, 1, 1.5% in feed, 10 days14 ± 1IP48–58[176]
Table 3. In vitro inhibitory activity of medicinal/plants towards S. agalactiae.
Table 3. In vitro inhibitory activity of medicinal/plants towards S. agalactiae.
S. agalactiae Origin/SourceMedicinal Herb/PlantExtraction MethodInhibitory MethodMIC MBCTemp
(°C)
Ref.
Strain ATCC 13813Cestrum auriculatumEthanol extract Agar diffusion>0.7 cm Unknown37[212]
Strain ATCC 13813Krameria triandraEthanol extract of root/ stem Agar diffusion>0.7 cmUnknown37[212]
Strain ATCC 13813 Sambucus peruvianaEthanol extract of leaf/shoot Agar diffusion>0.7 cmUnknown37[212]
Strain ATCC 13813Anredera diffusaMethanolAgar diffusion>0.7 cmUnknown37[212]
TilapiaCassia fistulaMethanol Microdilution24.9 mg/mL99.6 mg/mL37[213]
Freshwater fishPsidium guajavaMethanol (morin flavonoid)Microdilution300 μg/mL 37[209]
Freshwater fishPsidium guajavaMethanol (morin-3-O-lyxoside flavonoid) Microdilution200 μg/mLUnknown37[209]
Freshwater fishPsidium guajavaMethanol (morin-3-O-arabinoside flavonoid)Microdilution150 μg/mLUnknown37[209]
Freshwater fishPsidium guajavaMethanol (quercetin flavonoid)Microdilution200 μg/mLUnknown37[209]
Freshwater fishPsidium guajavaMethanol (quercetin-3-O-Arabinoside flavonoid)Microdilution200 μg/mLUnknown37[209]
TilapiaHibiscus sabdariffaWater and methanol extractMicrodilution4.7 mg/mL9.4 mg/mL37[213]
Tilapia Allium sativumWater extractSwab paper disc>500 μg/mLUnknown25[210]
TilapiaAllium sativumEthanol extractSwab paper disc125 μg/mLUnknown25[210]
TilapiaAllium sativumMethanol extractSwab paper disc500 μg/mLUnknown25[210]
TilapiaAndrographis paniculataWater extractSwab paper disc31.25 μg/mLUnknown25[216]
TilapiaAndrographis paniculataEthanol extractSwab paper disc250 μg/mLUnknown25[216]
TilapiaAndrographis paniculataMethanol extractSwab paper disc250 μg/mLUnknown25[216]
TilapiaCassia alataWater extractSwab paper disc500 μg/mLUnknown25[216]
Tilapia Cassia alataEthanol extractSwab paper disc250 μg/mLUnknown25[216]
TilapiaCassia alataMethanol extractSwab paper disc500 μg/mLUnknown25[216]
TilapiaGarcinia mangostanaWater extractSwab paper disc500 μg/mLUnknown25[216]
TilapiaGarcinia mangostanaEthanol extractSwab paper disc250 μg/mLUnknown25[216]
TilapiaGarcinia mangostanaMethanol extractSwab paper disc500 μg/mLUnknown25[216]
TilapiaPsidium guajavaWater extractSwab paper disc500 μg/mLUnknown25[216]
Tilapia Psidium guajavaEthanol extractSwab paper disc62.5 μg/mLUnknown25[216]
TilapiaPsidium guajavaMethanol extractSwab paper disc500 μg/mLUnknown25[216]
TilapiaStreblus asperWater extractSwab paper disc125 μg/mLUnknown25[216]
TilapiaStreblus asperEthanol extractSwab paper disc250 μg/mLUnknown25[216]
TilapiaStreblus asperMethanol extractSwab paper disc250 μg/mLUnknown25[216]
Strain 55118Helichrysum plicatumEthanolic extractDisk diffusion>13 mmUnknown37[178]
Strain 55118Nuphar luteaWater and ethanolic extractsDisk diffusionModerateUnknown37[178]
Strain 55118Salvia tomentosaWater extractDisk diffusionModerateUnknown37[178]
Strain 55118Genista lydiaEthanolic extractDisk diffusionModerateUnknown37[178]
Strain 55118Nymphaea albaWater, ethanol, methanolDisk diffusionWeakUnknown37[178]
Strain 55118Salvia verticillataMethanol and ethanol extractsDisk diffusionModerateUnknown37[178]
Strain 55118Phlomis pungensWater extractDisk diffusionModerateUnknown37[178]
Strain 55118Vinca minorEthanolic extractDisk diffusionStrongUnknown37[178]
Strain 55118Filipendula ulmariaWater extractDisk diffusionWeakUnknown 37[178]
Hybrid striped bassRosmarinus officinalisEthyl acetateDisk diffusion17 mm Unknown25[156]
TilapiaCinnamomum verumWater extractWell diffusion0.15 mg/mLUnknown35[167]
TilapiaAllium sativumWater extractWell diffusion2.50 mg/mLUnknown35[167]
TilapiaEugenia caryophyllusWater extractWell diffusion0.3 mg/mLUnknown35[167]
TilapiaThymus vulgarisWater extractWell diffusion0.6 mg/mLUnknown35[167]
Strain RITCC1913Papaver chelidonium foliumEthanol extract Well diffusion6.25 mg/mLUnknown37[211]
Strain RITCC1913Papaver armeniacus microstigmaEthanol extractWell diffusion6.25 mg/mLUnknown37[211]
Strain RITCC1913Papaver bracteatumEthanol extractWell diffusion6.25 mg/mLUnknown37[211]
Strain RITCC1913Papaver argemoneEthanol extractWell diffusion0.75 mg/mLUnknown37[211]
Strain RITCC1913Papaver dubiumEthanol extractWell diffusion3.125 mg/mLUnknown37[211]
Strain RITCC1913Papaver macrostomumEthanol extractWell diffusion1.56 mg/mLUnknown37[211]
UnknownDactyloctenium indicumMethanol at 100 mg/mLDisk diffusion10 mmUnknown37[214]
UnknownDactyloctenium indicumAqueous extract at 100 mg/mLDisk diffusion9.7 mmUnknown37[214]
UnknownTrichodesma indicumMethanol at 100 mg/mLDisk diffusion15.8 mmUnknown37[214]
UnknownAsteracantha longifoliaMethanol at 200 mg/mL Disk diffusion9 mmUnknown37[214]
UnknownMurraya koeinigiiMethanol extractMicrodilution0.39 mg mLUnknownUnknown[180]
Biotype 2 (Unknown)Aegle marmelosWater extract Well diffusion5 mg/mLUnknown35[215]
Biotype (Unknown)Emblica officinalisWater extractWell diffusion0.6 mg/mLUnknown 35[215]
Biotype 2 (Unknown)Moringa oleiferaWater extractWell diffusion0.6 mg/mLUnknown35[215]
Biotype 2 (Unknown)Azadirachta indicaChloroform extractWell diffusion10 mg/mLUnknown35[215]
Biotype 2-UnknownAzadirachta indicaEthanol extract Well diffusion1.25 mg/mLUnknown35[215]
Biotype 2 (Unknown)Toona sinensisChloroform extractWell diffusion0.15 mg/mLUnknown35[215]
Biotype 2 (Unknown)Toona sinensisEthanol extractWell diffusion0.6 mg/mLUnknown35[215]
Strain DMST 17129Rhodomyrtus tomentosaEthanol extractMicrodilution62.5 μg/mL250 μg/mL37[179]
TilapiaRhodomyrtus tomentosaEthanol extractMicrodilution31.2–62.5 μg/mL1000 μg/mL37[179]
Table 4. In vivo disease resistance of medicinal/plants towards S. agalactiae infection. IP= intraperitoneal injection; IM = intramuscular injection.
Table 4. In vivo disease resistance of medicinal/plants towards S. agalactiae infection. IP= intraperitoneal injection; IM = intramuscular injection.
Medicinal Herb/PlantExtraction MethodFish SpeciesDosage and DurationWater Temp. (°C)Route of ChallengeSurvival Rate (%)Ref.
Andrographis paniculataAqueousTilapiaAt ratios of 4:36 and 5:35 (w/w) in feed, 25IP100[210]
Rosmarinus officinalisLeavesTilapia8% in feed, 8 days26 ± 1 IP27[156]
Rosmarinus officinalisLeaves 16% in feed, 8 days26 ± 1IP38 [156]
Cinnamomum verumPowderTilapiaIn ratios of 1:20, 2:18, 3:316 in feed, 7 daysUnknownIP68.7[167]
C. verumAqueous TilapiaIn ratios of 1:30, 2:28, 3:16 (w/w) in feed, 7 daysUnknownIP60.5[167]
Cratoxylum formosumAqueous Tilapia0.5–1.5% in feed, 30 days56 ± 2IP44–90[216]
Sophora flavescensEthanolTilapia0.025–0.4% in feed, 30 days28 ± 2IP47.8–79.9[217]
Cinnamomum camphoraMethanol Tilapia2 g/kg feed, 90 days27–29IM80[185]
Carica papaya seedMethanolTilapia2 g/kg feed, 90 days27–29IM70[185]
Euphorbia hirtaMethanolTilapia2 g/kg feed, 90 days27–29IM70[185]
Zingiber officinaleEssential oilTilapia0.5% in feed, 55 days26.70 ± 1.17Gavage100[38]
Rhodomyrtus tomentosaEthanolTilapiaPre-treated S. agalactiae at 0.25 × MIC (31.2–62.5 μg mL)30IP90[179]
R. tomentosaEthanolTilapiaPre-treated S. agalactiae at 0.125 × MIC (31.2–62.5 μg/mL)30IP55[179]
R. tomentosaEthanolTilapiaPre-treated S. agalactiae at 0.25 × MIC 30IP50[179]
Camellia sinensisEthanolTilapia1 g/kg feed, 56 days28 ± 1 IP60[218]
C. sinensisEthanolTilapia2 g/kg feed, 56 days28 ± 1 IP83.33
C. sinensisEthanolTilapia4 g/kg feed, 56 days28 ± 1 IP76.68[218]
C. sinensisEthanolTilapia8 g/kg feed, 56 days28 ± 1 IP66.68[218]
Table 5. In vitro inhibitory activity of medicinal/plants to S. dysgalactiae.
Table 5. In vitro inhibitory activity of medicinal/plants to S. dysgalactiae.
Bacterial Origin/SourceMedicinal Herb/PlantExtraction/Essence MethodInhibitory MethodMIC or Zone of InhibitionMBCTemp
(°C)
Ref.
Cow mastitisPortulaca oleraceaAqueous extractDisk diffusion13.8–18 mm at 0.12–0.5 g/mLUnknown37[226]
Cow mastitisPortulaca oleraceaEthanolic extractDisk diffusion14.8–19.6 mm at 0.12–0.5 g/mLUnknown37[226]
Cow mastitisTaraxacum mongolicumAqueous extractDisk diffusion13.8–18 at 0.12–0.5 g/mLUnknown37[226]
Cow mastitisCinnamomum verumTrans-cinnamaldehyde Broth dilution0.05%0.4%37[225]
Cow mastitisEugenia caryophillisEugenolBroth dilution0.4%0.4%37[225]
Cow mastitisOriganum glandulosum CarvacrolBroth dilution0.4%0.8%37[225]
Cow mastitisOriganum glandulosumThymolBroth dilution0.4%0.9%37[225]
Cow mastitisTaraxacum mongolicumEthanolic extractDisk diffusion14.8–19.6 mm at 0.12–0.5 g/mLUnknown37[226]
Bovine mastitisPiper betleEthanolWell diffusion22–26 cm at 12.5–100 mg/mLUnknown37[229]
Bovine mastitisAgeratum conyzoidesEthanolWell diffusion14–17 cm at 12.5–100 mg/lUnknown37[229]
Bovine mastitisCurcuma domesticaEthanolWell diffusion18–21 cm at 12.5–100 mg/mLUnknown37[229]
Bovine mastitisWithania somnifera (root)MethanolWell diffusion8.86–17.5 mm at 31.25–250 mg/mLUnknown37[227]
Bovine mastitisCitrullus colocynthis pulp of fruitMethanolWell diffusion8.83–17.33 mm at 31.25–250 mg/mLUnknown37[227]
Bovine mastitisPiper nigrum (fruit)MethanolWell diffusion7.7–11.4 mm at 15.6–250 mg/mLUnknown37[227]
Table 6. In vitro inhibitory of medicinal /plants to S. parauberis.
Table 6. In vitro inhibitory of medicinal /plants to S. parauberis.
Bacterial Origin/SourceMedicinal Herb/PlantExtraction/Essence MethodInhibitory MethodMIC or Zone of InhibitionMBCTemp
(°C)
Ref.
S. parauberis KCTC 3651Epilobium pyrricholophumWater extractDisk diffusion9–14 mmUnknown25[198]
S. parauberis KCTC 3651 Aralia cordatWater extractDisk diffusion9–14 mm (4000 ppm)Unknown25[198]
S. parauberis KCTC 3651Quercus mongolicWater extractDisk diffusion9–14 mmUnknown25[198]
S. parauberis KCTC 3651Phtheirospermum japonicumWater extractDisk diffusion29–34 mm (4000 ppm)Unknown25[198]
S. parauberis KCTC 3651Geranium wilfordiWater extractDisk diffusion9–14 mmUnknown25[198]
S. parauberis KCTC 3651Carpinus laxifloraWater extractDisk diffusion9–14 mmUnknown25[198]
S. parauberis KCTC 3651Sedum takesimenseWater extractDisk diffusion9–14 mmUnknown25[198]
S. parauberis KCTC 3651Dystaenia takesimanaWater extractDisk diffusion19–24 mm (>5000 ppm)Unknown25[198]
Marine fishRubus coreanusEthanol extractDisk diffusion7.2 ± 0.07 mm at 100 µg/mLUnknown35–37[199]
Olive flounderEcklonia cavaMethanol extractMicrodilution1024 μg/mL (11 strains)Unknown25[193]
Olive flounderEcklonia cavan-hexane soluble (Hexane) fractionMicrodilution256–1024 μg/mL (11 strains)Unknown25[193]
Olive flounderEcklonia cavaDichloromethane fractionMicrodilution512- > 1024 μg/mL (11 strains)Unknown25[193]
Olive flounderEcklonia cavaEthyl acetate fractionMicrodilution512–1024 μg/mL (11 strains)Unknown25[193]
Olive flounderCruciferous vegetablesSulforaphaneMicrodilution0.5 mg/mL0.87 mg/mL37[191]
Olive flounderCruciferous vegetablesSulforapheneMicrodilution0.125 mg/mL1 mg/mL37[191]
Olive flounderCruciferous vegetablesIberinMicrodilution0.156 mg/mL1 mg/mL37[191]
Olive flounderCruciferous vegetablesErucin isothiocyanatesMicrodilution0.75 mg/mL0.75 mg/mL37[191]
Olive flounderCruciferous vegetablesAllyl isothiocyanatesMicrodilution0.75 mg/mL4 mg/mL37[191]
Olive flounderCruciferous vegetablesHexyl isothiocyanatesMicrodilution>4 mg/mL>4 mg/mL37[191]
Olive flounderCruciferous vegetablesPhenylethyl isothiocyanatesMicrodilution0.188 mg/mL0.31 ± 0.12 mg/mL37[191]
Olive flounderCruciferous vegetablesBenzyl isothiocyanatesMicrodilution0.5 mg/mL0.62 ± 0.25 mg/mL37[191]
Olive flounderCruciferous vegetablePhenyl isothiocyanatesMicrodilution1.5 ± 0.5 mg/mL2 ± 1.4 mg/mL37[191]
Olive flounderCruciferous vegetablesIndole-3-carbinolMicrodilution0.375 ± 0.14 mg/mL0.375 ± 0.14 mg/mL37[191]
Olive flounderRadish rootHydrolysate of radish rootMicrodilution0.44 ± 0.13 mg/mL0.5 mg/mL37[191]
Marine fishEcklonia cavaMethanol extractDisk diffusion17 mmUnknownUnknown[192]
Marine fishEcklonia stoloniferaMethanol extractDisk diffusion11 mmUnknownUnknown[192]
Marine fishEcklonia cavaEthyl acetate fractionMicrodilution256 μg/mLUnknownUnknown[192]
Marine fishEcklonia cavaButanol fractionDisk diffusion9 mmUnknownUnknown[192]
Olive flounderLavendular angustifoliaEssential oilMicrodilution0.063–0.5% (v/v)0.5–2.0% (v/v)27[183]
Olive flounderSyzygium aromaticumEssential oil Microdilution0.25–0.5% (v/v)0.5 (v/v)27[181]
Olive flounderSyzygium aromaticumEugenolMicrodilution0.125–1.0% (v/v)0.5–1.0% (v/v)27[181]
Olive flounderCymbopogon flexuosusEssential oil Microdilution0.016–0.125% (v/v)0.03–0.5% (v/v)27[200]
S. parauberis FP3287 Abies holophylla,Essential oilDisk diffusion11 mmUnknown28[201]
S. parauberis FP3287Pinus thunbergiiEssential oilDisk diffusion14 mmUnknown28[201]
S. parauberis FP3287 Tsuga sieboldiiEssential oilDisk diffusion9.75 ± 0.35 mmUnknown28[201]
S. parauberis FP3287 Pinus rigitaedaEssential oilDisk diffusion10.25 ± 1.77 mmUnknown28[201]
Table 7. In vitro inhibitory activity of medicinal /plants to S. uberis.
Table 7. In vitro inhibitory activity of medicinal /plants to S. uberis.
S. uberis Origin/SourceMedicinal Herb/PlantExtraction/Essence Inhibitory MethodMIC or Zone of InhibitionMBCTemp
(°C)
Ref.
Human mouth (9 strains)Cinnamomum cassia (Cinnamon bark)Aqueous extractDisk diffusion2–6 mmUnknown37[225]
Human mouth (9 strains)Cinnamomum cassia (Cinnamon bark)Essential oilDisk diffusion9 mmUnknown37[225]
Cow mastitisCinnamomum verumTrans-cinnamaldehyde Broth dilution0.1% v/v0.45% v/v39[225]
Cow mastitisEugenia caryophillisEugenolBroth dilution0.5% v/v0.4% v/v39[225]
Cow mastitisOriganum glandulosumCarvacrolBroth dilution0.8% v/v1.2% v/v39[225]
Cow mastitisOriganum glandulosumThymolBroth dilution0.6% v/v1.4% v/v39[225]
UnknownAcacia nilotica leafHot aqueous extractDisk diffusion9–22 mm at 21.25–20 mg/diskUnknownUnknown[232]
Cow mastitisMinthostachys verticillataEssential oilMicrodilution14.3–114.5 mg/mL114.5–229 mg/mL37[231]
Cow mastitisLimoneneSigma aldrichMicrodilution3.3–52.5 mg/mL210 mg/mL37[231]
Cow mastitisPunica granatumAqueous extractDisk diffusion25 mmUnknown37[190]
Cow mastitisPunica granatumMethanol extractDisk diffusion25 mmUnknown37[190]
PigUsnea barbataSupercritical carbon dioxide extractionMicrodilution5 µg/mLUnknown37[230]
PigUsnea barbataUsnic acidMicrodilution10 µg/mLUnknown37[230]

4. Conclusions and Future Studies

Streptococcosis causes massive mortality and economic loss in the global aquaculture sector. Traditionally, chemotherapeutic drugs and antibiotics have been applied for reducing the impacts of streptococcal infections on aquatic organism, but this may have serious adverse effects on aquatic ecosystems, wildlife and humans. Medicinal plants and their extracts may provide more environmentally beneficial alternatives to antibiotics for the treatment and control of streptococcal infections in aquaculture. The efficacy of a large numbers of plant species against S. iniae and S. agalactiae has been assessed in vitro, but less attention has been paid to the correlation of in vitro data with in vivo clinical efficacy. Most in vivo studies have used only two susceptible fish species, tilapia and rainbow trout, and have usually found variable increased clinical efficacy against infections. The efficacy of phytotherapy depends to a substantial extent on the form of application, such as powder, essential oils or extracts. In addition, the method of inclusion, dose, duration of feeding, level of supplementation and the size of the host and species all affect the bioavailability of plants and plant products for the host species and, thereby, immunity and resistance against infection. In the case of the dietary usage of phytotherapy, it must be considered that pelleting heat can affect the functionality and the actual dose of the active ingredients. Thus, future studies are required to guarantee the safe and full efficacy of phytotherapy when included in aquafeed. Further, the mode of action and the functionality of phytotherapeutic products in the entire body needs more clarification using modern techniques (e.g., omics). Although medicinal plants have been shown to have beneficial effects on human health and have a therapeutic effect against disease agents and on various organs of the body due to their active ingredients, their toxicity evaluation in the host is crucial before being formulated for use in aquaculture.

Author Contributions

H.V.D. by data collection and writing a part of draft, M.S. by conceptualization, writing a part of drat and editing, A.L. by editing the draft, S.S. by data collection and formatting, A.J.L. by editing the final draft, S.A. by data collection, E.R. by editing the draft. All authors have read and agreed to the published version of the manuscript.

Funding

Chiang Mai University (CoE 2566).

Data Availability Statement

This review paper has no data availability.

Acknowledgments

This research work was partially funded by Chiang Mai University, Thailand, and the University of Tehran, Iran.

Conflicts of Interest

The authors declare that they have no conflicts of interests to influence the work reported in this paper.

References

  1. Pradeep, P.J.; Suebsing, R.; Sirthammajak, S.; Kampeera, J.; Jitrakorn, S.; Saksmerprome, V.; Turner, W.; Palang, I.; Vanichviriyakit, R.; Senapin, S.; et al. Evidence of vertical transmission and tissue tropism of Streptococcosis from naturally infected red tilapia (Oreochromis spp.). Aquac. Rep. 2016, 3, 58–66. [Google Scholar] [CrossRef]
  2. Austin, B.; Austin, D.A. Bacterial Fish Pathogens: Disease of Farmed and Wild Fish; Springer International Publishing: Cham, Switzerland, 2016; pp. 48–66. [Google Scholar]
  3. Pereira, U.P.; Mian, G.F.; Oliveira, I.C.M.; Benchetrit, L.C.; Costa, G.M.; Figueiredo, H.C.P. Genotyping of Streptococcus agalactiae strains isolated from fish, human and cattle and their virulence potential in Nile tilapia. Vet. Microbiol. 2010, 140, 186–192. [Google Scholar] [CrossRef] [PubMed]
  4. Delannoy, C.M.; Crumlish, M.; Fontaine, M.C.; Pollock, J.; Foster, G.; Dagleish, M.P.; Turnbull, J.F.; Zadoks, R.N. Human Streptococcus agalactiae strains in aquatic mammals and fish. BMC Microbiol. 2013, 13, 41. [Google Scholar] [CrossRef] [PubMed]
  5. Ma, Y.P.; Ke, H.; Liang, Z.L.; Liu, Z.X.; Hao, L.; Ma, J.Y.; Li, Y.G. Multiple evolutionary selections involved in synonymous codon usages in the Streptococcus agalactiae genome. Int. J. Mol. Sci. 2016, 17, 277. [Google Scholar] [CrossRef]
  6. Gauthier, D.T. Bacterial zoonoses of fishes: A review and appraisal of evidence for linkages between fish and human infections. Vet. J. 2015, 203, 27–35. [Google Scholar] [CrossRef]
  7. Caipang, C.M.A.; Lucanas, J.B.; Lay-yag, C.M. Updates on the vaccination against bacterial diseases in tilapia, Oreochromis spp. and Asian seabass, Lates calcarifer. Aquac. Aquar. Conserv. Legis. 2014, 7, 184–193. [Google Scholar]
  8. Darwish, A.M.; Hobbs, M.S. Laboratory efficacy of amoxicillin for the control of Streptococcus iniae infection in blue tilapia. J. Aquat. Anim. Health 2005, 17, 197–202. [Google Scholar] [CrossRef]
  9. Soltani, M.; Jamshidi, S.; Sharifpour, I. Streptococcosis caused by Streptococcus iniae in farmed rainbow trout (Oncorhynchys mykiss) in Iran: Biophysical characteristics and pathogenesis. Bull. Eur. Assoc. Fish Pathol. 2005, 25, 95–106. [Google Scholar]
  10. Soltani, M.; Pirali, E.; Rasoli, A.; Shams, G.; Shafiei, S. Antibiotic residuals in some farmed rainbow trout (Oncorhynchus mykiss) of market size in Iran. Iran. J. Aquat. Anim. Health 2014, 1, 71–77. [Google Scholar] [CrossRef]
  11. Miranda, C.D.; Godoy, F.A.; Lee, M.R. Current status of the use of antibiotics and the antimicrobial resistance in the Chilean salmon farms. Front. Microbiol. 2018, 9, 1284. [Google Scholar] [CrossRef]
  12. Heuer, O.E.; Kruse, H.; Grave, K.; Collignon, P.; Karunasagar, I.; Angulo, F.J. Human health consequences of use of antimicrobial agents in aquaculture. Clin. Infec. Dis. 2009, 49, 1248–1253. [Google Scholar] [CrossRef] [PubMed]
  13. Smith, P.; Hiney, M.P.; Samuelsen, O.B. Bacterial resistance to antimicrobial agents used in fish farming: A critical evaluation of method and meaning. Ann. Rev. Fish Dis. 1994, 4, 273–313. [Google Scholar] [CrossRef]
  14. Cabello, F.C. Heavy use of prophylactic antibiotics in aquaculture: A growing problem for human and animal health and for the environment. Environ. Microbiol. 2006, 8, 1137–1144. [Google Scholar] [CrossRef] [PubMed]
  15. Amal, M.N.A.; Zamri-Saad, M. Streptococcosis in tilapia (Oreochromis niloticus): A review. Pertanika J. Trop. Agri. Sci. 2011, 34, 195–206. [Google Scholar]
  16. Bulfon, C.; Volpatti, D.; Galeotti, M. Current research on the use of plant-derived products in farmed fish. Aquac. Res. 2015, 46, 513–551. [Google Scholar] [CrossRef]
  17. Okocha, R.C.; Olatoye, I.O.; Adedeji, O.B. Food safety impacts of antimicrobial use and their residues in aquaculture. Publ. Health Rev. 2018, 39, 21. [Google Scholar] [CrossRef]
  18. Ji, S.C.; Jeong, G.S.; Gwang-Soon, I.M.; Lee, S.W.; Yoo, J.H.; Takii, K. Dietary medicinal herbs improve growth performance, fatty acid utilization, and stress recovery of Japanese flounder. Fish. Sci. 2007, 73, 70–76. [Google Scholar] [CrossRef]
  19. Gabriel, N.N. Review on the progress in the role of herbal extracts in tilapia culture. Cogent Food Agric. 2019, 5, 1619651. [Google Scholar] [CrossRef]
  20. Elumalai, P.; Kurian, A.; Lakshmi, S.; Faggio, C.; Esteban, M.Á.; Ringø, E. Herbal immunomodulators in aquaculture. Rev. Fish. Sci. Aquacul. 2020, 29, 33–57. [Google Scholar] [CrossRef]
  21. Yılmaz, S.; Ergün, S. Effects of garlic and ginger oils on hematological and biochemical variables of sea bass (Dicentrarchus labrax). J. Aquat. Anim. Health 2012, 24, 219–224. [Google Scholar] [CrossRef]
  22. Yılmaz, S.; Ergün, S.; Celik, E.Ş. Effects of herbal supplements on growth performance of sea bass (Dicentrarchus labrax): Change in body composition and some blood parameters. J. BioSci. Biotech. 2012, 1, 217–222. [Google Scholar]
  23. Yılmaz, S.; Ergün, S.; Çelik, E.Ş. Effect of dietary herbal supplements on some physiological conditions of sea bass Dicentrarchus labrax. J. Aquat. Anim. Health 2013, 25, 98–103. [Google Scholar] [CrossRef] [PubMed]
  24. Yılmaz, S.; Ergün, S.; Çelik, E.Ş. Effect of dietary spice supplementations on welfare status of sea bass (Dicentrarchus labrax L). Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 2016, 86, 229–237. [Google Scholar] [CrossRef]
  25. Mahdavi, M.; Hajimoradloo, A.; Ghorbani, R. Effect of Aloe vera extract on growth parameters of common carp (Cyprinus carpio). World J.Med. Sci. 2013, 9, 55–60. [Google Scholar] [CrossRef]
  26. Gabriel, N.N.; Qiang, J.; He, J.; Ma, X.Y.; Kpundeh, M.D.; Xu, P. Dietary Aloe vera supplementation on growth performance, some haemato-biochemical parameters and disease resistance against Streptococcus iniae in tilapia (GIFT). Fish Shellfish Immunoo. 2015, 44, 504–514. [Google Scholar] [CrossRef]
  27. Gabriel, N.N.; Qiang, J.; Ma, X.Y.; He, J.; Xu, P.; Liu, K. Dietary Aloe vera improves plasma lipid profile, antioxidant, and hepatoprotective enzyme activities in GIFT-tilapia (Oreochromis niloticus) after Streptococcus iniae challenge. Fish Physiolo. Biochem. 2015, 41, 1321–1332. [Google Scholar] [CrossRef]
  28. Yang, W.; Li, A. Isolation and characterization of Streptococcus dysgalactiae from diseased Acipenser schrenckii. Aquaculture 2009, 294, 14–17. [Google Scholar] [CrossRef]
  29. Soltani, M.; Lymbery, A.; Song, S.K.; Hosseini Shekarabi, P. Adjuvant effects of medicinal herbs and probiotics for fish vaccines. Rev. Aquac. 2019, 11, 1325–1341. [Google Scholar] [CrossRef]
  30. Yılmaz, S.; Ergün, S. Dietary supplementation with allspice Pimenta dioica reduces the occurrence of streptococcal disease during first feeding of Mozambique Tilapia Fry. J. Aquat. Anim. Health 2014, 26, 144–148. [Google Scholar] [CrossRef]
  31. Yilmaz, S.; Ergün, S.; Kaya, H.; Gürkan, M. Influence of Tribulus terrestris extract on the survival and histopathology of Oreochromis mossambicus (Peters, 1852) fry before and after Streptococcus iniae infection. J. Appl. Ichthyol. 2014, 30, 994–1000. [Google Scholar] [CrossRef]
  32. Yilmaz, S. Effects of dietary blackberry syrup supplement on growth performance, antioxidant, and immunological responses, and resistance of Nile tilapia, Oreochromis niloticus to Plesiomonas shigelloides. Fish Shellfish Immunol. 2019, 84, 1125–1133. [Google Scholar] [CrossRef] [PubMed]
  33. Yilmaz, S. Effects of dietary caffeic acid supplement on antioxidant, immunological and liver gene expression responses, and resistance of Nile tilapia, Oreochromis niloticus to Aeromonas veronii. Fish Shellfish Immunol. 2019, 86, 384–392. [Google Scholar] [CrossRef] [PubMed]
  34. Gurkan, M.; Yilmaz, S.; Hasan, K.A.Y.A.; Ergun, S.; Alkan, S. Influence of three spice powders on the survival and histopathology of Oreochromis mossambicus before and after Streptococcus iniae infection. Mar. Sci. Technol. Bull. 2015, 4, 1–5. [Google Scholar]
  35. Olusola, S.E.; Emikpe, B.O.; Olaifa, F.E. The potentials of medicinal plant extracts as bio-antimicrobials in aquaculture. Int. Medic. Aromat. Plants 2013, 3, 404–412. [Google Scholar]
  36. Reverter, M.; Bontemps, N.; Lecchini, D.; Banaigs, B.; Sasal, P. Use of plant extracts in fish aquaculture as an alternative to chemotherapy: Current status and future perspectives. Aquaculture 2014, 433, 50–61. [Google Scholar] [CrossRef]
  37. Acar, Ü.; Kesbiç, O.S.; Yılmaz, S.; Gültepe, N.; Türker, A. Evaluation of the effects of essential oil extracted from sweet orange peel (Citrus sinensis) on growth rate of tilapia (Oreochromis mossambicus) and possible disease resistance against Streptococcus iniae. Aquaculture 2015, 437, 282–286. [Google Scholar] [CrossRef]
  38. Brum, A.; Pereira, S.A.; Owatari, M.S.; Chagas, E.C.; Chaves, F.C.M.; Mouriño, J.L.P.; Martins, M.L. Effect of dietary essential oils of clove basil and ginger on Nile tilapia (Oreochromis niloticus) following challenge with Streptococcus agalactiae. Aquaculture 2017, 468, 235–243. [Google Scholar] [CrossRef]
  39. Tafi, A.A.; Meshkini, S.; Tukmechi, A.; Alishahi, M.; Noori, F. Immunological and anti-streptococcal effects of Salvia officinalis and Aloe vera extracts supplemented feed in rainbow trout (Oncorhynchus mykiss). Kafkas Üniversitesi Vet. Fakültesi Derg. 2018, 24, 365–370. [Google Scholar] [CrossRef]
  40. Vazirzadeh, A.; Jalali, S.; Farhadi, A. Antibacterial activity of Oliveria decumbens against Streptococcus iniae in Nile tilapia (Oreochromis niloticus) and its effects on serum and mucosal immunity and antioxidant status. Fish Shellfish Immunol. 2019, 94, 407–416. [Google Scholar] [CrossRef]
  41. Kim, J.; Lee, K.W.; Jeong, H.S.; Ansary, M.W.R.; Kim, H.S.; Kim, T.; Kwon, M.G.; Cho, S.H. Oral administration effect of yacon, ginger and blueberry on the growth, body composition and plasma chemistry of juvenile olive flounder (Paralichthys olivaceus) and immunity test against Streptococcus iniae compared to a commercial probiotic, Lactobacillus fermentum. Aquac. Rep. 2019, 15, 100212. [Google Scholar] [CrossRef]
  42. Foysal, M.J.; Alam, M.; Momtaz, F.; Chaklader, M.R.; Siddik, M.A.; Cole, A.; Fotedar, R.; Rahman, M.M. Dietary supplementation of garlic (Allium sativum) modulates gut microbiota and health status of tilapia (Oreochromis niloticus) against Streptococcus iniae infection. Aquac. Res. 2019, 50, 2107–2116. [Google Scholar] [CrossRef]
  43. Wilkinson, H.W.; Thacker, L.G.; Facklam, R.R. Nonhemolytic group B streptococci of human, bovine, and ichthyic origin. Infect. Immun. 1973, 7, 496–498. [Google Scholar] [CrossRef] [PubMed]
  44. Evans, J.J.; Klesius, P.H.; Gilbert, P.M.; Shoemaker, C.A.; Al-Sarawi, M.A.; Landsberg, J.; Durendez, R.; Al-Marzouk, A.; Al-Zenki, S. Characterization of β-hemolytic group B Streptococcus agalactiae in cultured seabream, Sparus auratus and mullet, Liza klunzingeri, in Kuwait. J. Fish Dis. 2002, 25, 505–513. [Google Scholar] [CrossRef]
  45. Zappulli, V.; Mazzariol, S.; Cavicchioli, L.; Petterino, C.; Bargelloni, L.; Castagnaro, M. Fatal necrotizing fasciitis and myositis in a captive common bottlenose dolphin (Tursiops truncatus) associated with Streptococcus agalactiae. J. Vet. Diagn. Investig. 2005, 17, 617–622. [Google Scholar] [CrossRef] [PubMed]
  46. Taurisano, N.D.; Butler, B.P.; Stone, D.; Hariharan, H.; Fields, P.J.; Ferguson, H.W.; Haulena, M.; Cotrell, P.; Nielsen, O.; Raverty, S. Streptococcus phocae in marine mammals of northeastern Pacific and Arctic Canada: A retrospective analysis of 85 postmortem investigations. J. Wildl. Dis. 2018, 54, 101–111. [Google Scholar] [CrossRef] [PubMed]
  47. Agnew, W.; Barnes, A.C. Streptococcus iniae: An aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet. Microbiol. 2007, 122, 1–15. [Google Scholar] [CrossRef]
  48. Liu, G.; Zhu, J.L.; Chen, K.M.; Gao, T.T.; Yao, H.C.; Liu, Y.J.; Zhang, W.; Lu, C.P. Development of Streptococcus agalactiae vaccines for tilapia. Dis. Aquat. Org. 2016, 122, 163–170. [Google Scholar] [CrossRef]
  49. Maekawa, S.; Wang, Y.-T.; Yoshida, T.; Wang, P.C.; Chen, S.-C. Group C Streptococcus dysgalactiae infection in fish. J. Fish Dis. 2020, 43, 963–970. [Google Scholar] [CrossRef]
  50. Eldar, A.; Bejerano, Y.; Livoff, A.; Horovitcz, A.; Bercovier, H. Experimental streptococcal meningoencephalitis in cultured fish. Vet. Microbiol. 1995, 43, 33–40. [Google Scholar] [CrossRef]
  51. Evans, J.J.; Klesius, P.H.; Shoemaker, C.A.; Pasnik, D.J. Identification and epidemiology of Streptococcus iniae and S. agalactiae in tilapias Oreochromis spp. In Proceedings of the 7th International Symposium on Tilapia in Aquaculture, American Tilapia Association, Vera Cruz, Mexico, 9 June 2006; pp. 25–42. [Google Scholar]
  52. Salvador, R.; Muller, E.E.; Freitas, J.C.; Leonhadt, J.H.; Giordano, L.G.P.; Dias, J.A. Isolation and characterization of Streptococcus spp. group B in Nile Tilapia (Oreochromis niloticus) reared in hapas nets and earth nurseries in the northern region of Parana State, Brazil. Ciência Rural. 2005, 35, 1374–1378. [Google Scholar] [CrossRef]
  53. Romalde, J.L.; Ravelo, C.; Valdés, I.; Magariños, B.; de la Fuente, E.; San Martín, C.; Avendaño-Herrera, R.; Toranzo, A.E. Streptococcus phocae, an emerging pathogen for salmonid culture. Vet. Microbiol. 2008, 130, 198–207. [Google Scholar] [CrossRef] [PubMed]
  54. Netto, L.N.; Leal, C.A.G.; Figueiredo, H.C.P. Streptococcus dysgalactiae as an agent of septicaemia in Nile tilapia, Oreochromis niloticus (L.). J. Fish Dis. 2011, 34, 251–254. [Google Scholar] [CrossRef] [PubMed]
  55. Sepahi, A.; Heidarieh, M.; Mirvaghefi, A.; Rafiee, G.R.; Farid, M.; Sheikhzadeh, N. Effects of water temperature on the susceptibility of rainbow trout to Streptococcus agalactiae. Acta Sci. Vet. 2013, 41, 1097. [Google Scholar]
  56. Iregui, C.A.; Comas, J.; Vasquez, G.M.; Verjan, N. Experimental early pathogenesis of Streptococcus agalactiae infection in red tilapia Oreochromis spp. J. Fish Dis. 2016, 39, 205–215. [Google Scholar] [CrossRef]
  57. Lazado, C.C.; Fridman, S.; Sinai, T.; Zilberg, D. First report of Streptococcus parauberis in a cultured freshwater ornamental fish, the ram cichlid Mikrogeophagus ramirezi (Myers & Harry, 1948). J. Fish Dis. 2017, 41, 161–164. [Google Scholar] [CrossRef]
  58. Luo, X.; Fu, X.; Liao, G.; Chang, O.; Huang, Z.; Li, N. Isolation, pathogenicity and characterization of a novel bacterial pathogen Streptococcus uberis from diseased mandarin fish (Siniperca chuatsi). Microb. Pathog. 2017, 107, 380–389. [Google Scholar] [CrossRef]
  59. Soltani, M.; Baldisserotto, B.; Hosseini Shekarabi, S.P.; Shafiei, S.; Bashiri, M. Lactococcosis a re-emerging disease in aquaculture: Disease significant and phytotherapy. Vet. Sci. 2021, 8, 181. [Google Scholar] [CrossRef]
  60. Haghighi Karsidani, S.; Soltani, M.; Nikbakhat-Brojeni, R.; Ghasemi, M.; Skall, S.F. Molecular epidemiology of zoonotic streptococcosis/lactococcosis in rainbow trout (Oncorhynchus mykiss) aquaculture in Iran. Iran. J. Microbiol. 2010, 2, 198–209. [Google Scholar]
  61. Eldar, A.; Bejerano, Y.; Bercovier, H. Streptococcus shiloi and Streptococcus difficile: Two new streptococcal species causing a meningoencephalitis in fish. Curr. Microbiol. 1994, 28, 139–143. [Google Scholar] [CrossRef]
  62. Delamare-Deboutteville, J.; Bowater, R.; Condon, K.; Reynolds, A.; Fisk, A.; Aviles, F.; Barnes, A.C. Infection and pathology in Queensland grouper, Epinephelus lanceolatus, (Bloch), caused by exposure to Streptococcus agalactiae via different routes. J. Fish Dis. 2015, 38, 1021–1035. [Google Scholar] [CrossRef]
  63. Roberts, R.J. Fish Pathology, 4th ed.; John Wiley & Sons: Hoboken, NJ, USA, 2012. [Google Scholar]
  64. Gibello, A.; Mata, A.I.; Blanco, M.M.; Casamayor, A.; Domínguez, L.; Fernández-Garayzabal, J.F. First identification of Streptococcus phocae isolated from Atlantic salmon (Salmo salar). J. Clin. Microbiol. 2005, 43, 526–527. [Google Scholar] [CrossRef] [PubMed]
  65. Zlotkin, A.; Chilmonczyk, S.; Eyngor, M.; Hurvitz, A.; Ghittino, C.; Eldar, A. Trojan horse effect: Phagocyte-mediated Streptococcus iniae infection of fish. Infect. Immun. 2003, 71, 2318–2325. [Google Scholar] [CrossRef]
  66. Bromage, E.S.; Thomas, A.; Owens, L. Streptococcus iniae, a bacterial infection in barramundi Lates calcarifer. Dis. Aquat. Org. 1999, 36, 177–181. [Google Scholar] [CrossRef] [PubMed]
  67. Buchanan, J.T.; Stannard, J.A.; Lauth, X.; Ostland, V.E.; Powell, H.C.; Westerman, M.E.; Nizet, V.S. iniae phosphoglucomutase is a virulence factor and a target for vaccine development. Infect. Immun. 2005, 73, 6935–6944. [Google Scholar] [CrossRef] [PubMed]
  68. Lowe, B.A.; Miller, J.D.; Neely, M.N. Analysis of the polysaccharide capsule of the systemic pathogen Streptococcus iniae and its implications in virulence. Infect. Immun. 2007, 75, 1255–1264. [Google Scholar] [CrossRef] [PubMed]
  69. Locke, J.B.; Colvin, K.M.; Datta, A.K.; Patel, S.K.; Naidu, N.N.; Neely, M.N.; Nizet, V.; Buchanan, J.T. Streptococcus iniae capsule impairs phagocytic clearance and contributes to virulence in fish. J. Bacteriol. 2007, 189, 1279–1287. [Google Scholar] [CrossRef]
  70. Baron, M.; Bolduc, G.; Goldberg, M.; Auperin, T.; Madoff, L. Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an action-dependent mechanism. J. Biol. Chem. 2004, 279, 24714–24723. [Google Scholar] [CrossRef]
  71. Baron, M.; Filman, D.; Prophete, G.; Hogle, J.; Madoff, L. Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B Streptococci into host cells. J. Biol. Chem. 2007, 282, 10526–10536. [Google Scholar] [CrossRef] [Green Version]
  72. Barnes, A.C.; Young, F.M.; Horne, M.T.; Ellis, A.E. Streptococcus iniae: Serological differences, presence of capsule and resistance to immune serum killing. Dis. Aquat. Org. 2003, 53, 241–247. [Google Scholar] [CrossRef]
  73. Barnes, A.C.; Horne, M.T.; Ellis, A.E. Streptococcus iniae expresses a cell surface non-immune trout immunoglobulin binding factor when grown in normal trout serum. Fish Shellfish. Immunol. 2003, 15, 425–431. [Google Scholar] [CrossRef]
  74. Nizet, V. Streptococcal beta-hemolysins: Genetics and role in disease pathogenesis. Trends Microbiol. 2002, 10, 575–580. [Google Scholar] [CrossRef]
  75. Nizet, V.; Beall, B.; Bast, D.J.; Datta, V.; Kilburn, L.; Low, D.E.; De Azavedo, J.C. Genetic locus for streptolysin S production by group A streptococcus. Infect. Immun. 2000, 68, 4245–4254. [Google Scholar] [CrossRef] [PubMed]
  76. Fuller, J.D.; Camus, A.C.; Duncan, C.L.; Nizet, V.; Bast, D.J.; Thune, R.L.; Low, D.E.; de Azavedo, J.C. Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of S. iniae disease. Infect. Immun. 2002, 70, 5730–5739. [Google Scholar] [CrossRef] [PubMed]
  77. Locke, J.B.; Colvin, K.M.; Varki, N.; Vicknair, M.R.; Nizet, V.; Buchanan, J.T. Streptococcus iniae β-hemolysin streptolysin S is a virulence factor in fish infection. Dis. Aquat. Org. 2007, 76, 17–26. [Google Scholar] [CrossRef]
  78. Locke, J.B.; Aziz, R.K.; Vicknair, M.R.; Nizet, V.; Buchanan, J.T. Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development. PLoS ONE 2008, 3, e2824. [Google Scholar] [CrossRef]
  79. Aviles, F.; Zhang, M.M.; Chan, J.; Delamare-Deboutteville, J.; Green, T.J.; Dang, C.; Barnes, A.C. The conserved surface M-protein SiMA of Streptococcus iniae is not effective as a cross-protective vaccine against differing capsular serotypes in farmed fish. Vet. Microbiol. 2013, 162, 151–159. [Google Scholar] [CrossRef]
  80. Soh, K.Y.; Loh, J.M.S.; Hall, C.; Proft, T. Functional analysis of two novel Streptococcus iniae virulence factors using a zebrafish infection model. Microorganisms 2020, 8, 1361. [Google Scholar] [CrossRef]
  81. Baiano, J.C.; Tumbol, R.A.; Umapathy, A.; Barnes, A.C. Identification and molecular characterisation of a fibrinogen binding protein from Streptococcus iniae. BMC Microbiol. 2008, 8, 67. [Google Scholar] [CrossRef] [Green Version]
  82. Lang, S.; Palmer, M. Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J. Biol. Chem. 2003, 278, 38167–38173. [Google Scholar] [CrossRef]
  83. Rajagopal, L. Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol. 2009, 4, 201–221. [Google Scholar] [CrossRef]
  84. Mishra, A.; Nam, G.H.; Gim, J.A.; Lee, H.E.; Jo, A.; Kim, H.S. Current challenges of Streptococcus infection and effective molecular, cellular, and environmental control methods in aquaculture. Mol. Cells 2018, 41, 495. [Google Scholar] [CrossRef] [PubMed]
  85. Ancona, R.J.; Ferrieri, P.; Williams, P.P. Maternal factors that enhance the acquisition of Group B streptococci by newborn infants. J. Med. Microbiol. 1980, 13, 273–280. [Google Scholar] [CrossRef] [PubMed]
  86. Bisno, A.L.; Craven, D.E.; McCabe, W.R. M proteins of group G streptococci isolated from bacteremic human infections. Infect. Immun. 1987, 55, 753–757. [Google Scholar] [CrossRef] [PubMed]
  87. Brandt, C.M.; Spellerberg, B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin. Infect. Dis. 2009, 49, 766–772. [Google Scholar] [CrossRef]
  88. Lindgren, P.E.; McGavin, M.J.; Signäs, C.; Guss, B.; Gurusiddappa, S.; Höök, M.; Lindberg, M. Two different genes coding for fibronectin-binding proteins from Streptococcus dysgalactiae. The complete nucleotide sequences and characterization of the binding domains. Eur. J. Biochem. 1993, 214, 819–827. [Google Scholar] [CrossRef]
  89. Lindgren, P.E.; Signäs, C.; Rantamäki, L.; Lindberg, M. A fibronectin-binding protein from Streptococcus equisimilis: Characterization of the gene and identification of the binding domain. Vet. Microbiol. 1994, 41, 235–247. [Google Scholar] [CrossRef]
  90. Kline, J.B.; Xu, S.; Bisno, A.L.; Collins, C.M. Identification of a fibronectin-binding protein (GfbA) in pathogenic group G streptococci. Infect. Immun. 1996, 64, 2122–2129. [Google Scholar] [CrossRef]
  91. Lo, H.H.; Cheng, W.S. Distribution of virulence factors and association with emm polymorphism or isolation site among beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis. APMIS 2015, 123, 45–52. [Google Scholar] [CrossRef]
  92. Rohde, M.; Talay, S.R.; Rasmussen, M. Molecular mechanisms of Streptococcus dysgalactiae subsp equisimilis enabling intravascular persistence. Microbes Infect. 2012, 14, 329–334. [Google Scholar] [CrossRef]
  93. Gherardi, G.; Imperi, M.; Palmieri, C.; Magi, G.; Facinelli, B.; Baldassarri, L.; Pataracchia, M.; Creti, R. Genetic diversity and virulence properties of Streptococcus dysgalactiae subsp. equisimilis from different sources”. J. Med. Microbiol. 2014, 63, 90–98. [Google Scholar] [CrossRef]
  94. Sjöbring, U.; Björck, L.; Kastern, W. Streptococcal protein G. Gene structure and protein binding properties. J. Biol. Chem. 1991, 266, 399–405. [Google Scholar] [CrossRef]
  95. Watanabe, S.; Shimomura, Y.; Ubukata, K.; Krikae, T.; Tohru, M.A. Concomitant regulation of host tissue-destroying virulence factors and carbohydrate metabolism during invasive diseases induced by group g streptococci. J. Infect. Dis. 2013, 208, 1482–1493. [Google Scholar] [CrossRef] [PubMed]
  96. Smyth, D.; Cameron, A.; Davies, M.R.; McNeilly, C.; Hafner, L.; Sriprakash, K.S.; McMillan, D.J. DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial peptide LL-37. Infect. Immun. 2014, 82, 2337–2344. [Google Scholar] [CrossRef] [PubMed]
  97. Sachse, S.; Seidel, P.; Gerlach, D.; Günther, E.; Rödel, J.; Straube, E.; Schmidt, K.H. Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: Genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)). FEMS Immunol. Med. Microbiol. 2002, 34, 159–167. [Google Scholar] [CrossRef]
  98. Oliver, S.P.; Almeida, R.A.; Calvinho, L.F. Virulence factors of Streptococcus uberis isolated from cows with mastitis. Zent. Vet. B 1998, 45, 461–471. [Google Scholar] [CrossRef]
  99. Kaczorek, E.; Malaczewska, J.; Wojcik, R.; Siwicki, A.K. Biofilm production and other virulence factors in Streptococcus spp. isolated from clinical cases of bovine mastitis in Poland. BMC Vet. Res. 2017, 13, 398. [Google Scholar] [CrossRef]
  100. Reinoso, E.B.; Lasagno, M.C.; Dieser, S.A.; Odierno, L.M. Distribution of virulence-associated genes in Streptococcus uberis isolated from bovine mastitis. FEMS Microbiol. Lett. 2011, 318, 183–188. [Google Scholar] [CrossRef]
  101. Gao, Y.; Liu, Y.; Wang, P.; Mo, Z.; Li, J.; Liu, S.; Li, G.; Zhu, M.; Li, G. Isolation, identification and vaccine development of serotype III Streptococcus parauberis in turbot (Scophthalmus maximus) in China. Aquaculture 2021, 538, 736525. [Google Scholar] [CrossRef]
  102. Silayeva, O.; Engelstädter, J.; Barnes, A.C. Evolutionary epidemiology of Streptococcus iniae: Linking mutation rate dynamics with adaptation to novel immunological landscapes. Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 2020, 85, 104435. [Google Scholar] [CrossRef]
  103. Genteluci, G.L.; Silva, L.G.; Souza, M.C.; Glatthardt, T.; de Mattos, M.C.; Ejzemberg, R.; Alviano, C.S.; Figueiredo, A.M.S.; Bernadete, T.F.C. Assessment and characterization of biofilm formation among human isolates of Streptococcus dysgalactiae subsp. equisimilis. Int. J. Med. Microbiol. 2015, 305, 937–947. [Google Scholar] [CrossRef]
  104. Martin, M.C.-S.; González-Contreras, A.; Avendaño-Herrera, R. Infectivity study of Streptococcus phocae to seven fish and mammalian cell lines by confocal microscopy. J. Fish Dis. 2012, 35, 431–436. [Google Scholar] [CrossRef] [PubMed]
  105. Salazar, S.; Oliver, C.; Yáñez, A.J.; Avendaño-Herrera, R. Comparative analysis of innate immune responses to Streptococcus phocae strains in Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss). Fish Shellfish. Immunol. 2016, 51, 97–103. [Google Scholar] [CrossRef]
  106. González-Contreras, A.; Magariños, B.; Godoy, M.; Irgang, R.; Toranzo, A.E.; Avendaño-Herrera, R. Surface properties of Streptococcus phocae strains isolated from diseased Atlantic salmon, Salmo salar L. J. Fish Dis. 2011, 34, 203–215. [Google Scholar] [CrossRef] [PubMed]
  107. Soltani, M.; Alishahi, M.; Mirzargar, S.; Nikbakht, G. Vaccination of rainbow trout against Streptococcus iniae infection comparison of different routes of administration and different vaccine. Iran. J. Fish. Sci. 2007, 7, 129–140. [Google Scholar]
  108. Soltani, M.; Pirali Kheirabadi, A.; Taherimirkahead, E.; Shafie, S.; Mohamadian, S.; Roholahi, S. Molecular study of streptococcosis/lactococcosis distribution in farmed rainbow trout in Charmahal–va-Bakhteyari and Kohgiloyeh-va-Boyerahmad provinces, Iran. Iran. J. Epidemiol. 2013, 9, 59–68. [Google Scholar]
  109. Bromage, E.S.; Owens, L. Infection of barramundi Lates calcarifer with Streptococcus iniae: Effects of different routes of exposure. Dis. Aquat. Org. 2002, 52, 199–205. [Google Scholar] [CrossRef]
  110. Klesius, P.; Evans, J.; Shoemaker, C.; Yeh, H.; Goodwin, A.; Adams, A.; Thompson, K. Rapid detection and identification of Streptococcus iniae using a monoclonal antibody-based indirect fluorescent antibody technique. Aquaculture 2006, 258, 180–186. [Google Scholar] [CrossRef]
  111. Suanyuk, N.; Kong, F.; Ko, D.; Gilbert, G.; Supamattaya, K. Occurrence of rare genotypes of Streptococcus agalactiae in cultured red tilapia Oreochromis sp. and Nile tilapia O. niloticus in Thailand-relationship to human isolates? Aquaculture 2008, 284, 35–40. [Google Scholar] [CrossRef]
  112. Suanyuk, N.; Sukkasame, N.; Tanmark, N.; Yoshida, T.; Itami, T.; Thune, R.L.; Tantikitti, C.; Supamattaya, K. Streptococcus iniae infection in cultured Asian sea bass (Lates calcarifer) and red tilapia (Oreochromis sp.) in southern Thailand. Songklanakarin J. Sci. Technol. 2010, 32, 341–348. [Google Scholar]
  113. Duremdez, R.; Al-Marzouk, A.; Qasem, J.A.; Al-Harbi, A.; Gharabally, H. Isolation of Streptococcus agalactiae from cultured silver pomfret, Pampus argenteus (Euphrasen), in Kuwait. J. Fish Dis. 2004, 27, 307–310. [Google Scholar] [CrossRef]
  114. Kim, J.H.; Gomez, D.K.; Choresca, C.H.; Park, S.C. Detection of major bacterial and viral pathogens in trash fish used to feed cultured flounder in Korea. Aquaculture 2007, 272, 105–110. [Google Scholar] [CrossRef]
  115. Garcia, J.C.; Klesius, P.H.; Evans, J.J.; Shoemaker, C.A. Non infectivity of cattle S. agalactiae in Nile tilapia (O. niloticus) and channel catfsh (Ictalurus ounctatus). Aquaculture 2008, 281, 151–154. [Google Scholar] [CrossRef]
  116. Nomoto, R.; Munasinghe, L.I.; Jin, D.H.; Shimahara, Y.; Yasuda, H.; Nakamura, A.; Misawa, N.; Itami, T.; Yoshida, T. Lancefield group C Streptococcus dysgalactiae infection responsible for fish mortalities in Japan. J. Fish Dis. 2004, 27, 679–686. [Google Scholar] [CrossRef]
  117. Zhou, S.M.; Li, A.X.; Ma, Y.; Liu, R.M. Isolation, identification and characteristics of 16S rDNA gene sequences of the pathogens responsible for the Streptococcicosis in cultured fish. Acta Sci. Nat. Univ. Sunyatseni 2007, 46, 68–71. [Google Scholar]
  118. Abdelsalam, M.; Chen, S.C.; Yoshida, T. Phenotypic and genetic characterizations of Streptococcus dysgalactiae strains isolated from fish collected in Japan and other Asian countries. FEMS Microbiol. Lett. 2010, 302, 32–38. [Google Scholar] [CrossRef]
  119. Pourgholam, R.; Laloei, F.; Saeidi, A.A.; Ghoroghi, A.; Taghavi, M.J.; Zahedi, A.; Safari, R.; Sharifpour, E.; Sepahdari, A. Molecular identification of some causative agents of streptococcosis isolated in farmed rainbow trout (Oncorhynchus mykiss, walbaum) in Iran. Iran. J. Fish. Sci. 2011, 10, 109–122. [Google Scholar]
  120. Williams, A.M.; Collins, M.D. Molecular taxonomic studies on Streptococcus uberis types I and II. Description of Streptococcus parauberis sp. nov. J. Appl. Microbiol. 1990, 68, 485–490. [Google Scholar] [CrossRef]
  121. Domeénech, A.; Derenaáandez-Garayzábal, J.F.; Pascual, C.; Garcia, J.A.; Cutuli, M.T.; Moreno, M.A.; Collins, M.D.; Dominguez, L. Streptococcosis in cultured turbot, Scopthalmus maximus (L.), associated with Streptococcus parauberis. J. Fish Dis. 1996, 19, 33–38. [Google Scholar] [CrossRef]
  122. Haines, A.N.; Gauthier, D.T.; Nebergall, E.E.; Cole, S.D.; Nguyen, K.M.; Rhodes, M.W.; Vogelbein, W.K. First report of Streptococcus parauberis in wild finfish from North America. Vet. Microbiol. 2013, 166, 270–275. [Google Scholar] [CrossRef]
  123. Haines, A.; Nebergall, E.; Besong, E.; Council, K.; Lambert, O.; Gauthier, D. Draft genome sequences for seven Streptococcus parauberis isolates from wild fish in the Chesapeake Bay. Genome Announc. 2016, 4, e00741-16. [Google Scholar] [CrossRef]
  124. Baeck, G.W.; Kim, J.H.; Gomez, D.K.; Park, S.C. Isolation and characterization of Streptococcus sp. from diseased flounder (Paralichthys olivaceus) in Jeju Island. J. Vet. Sci. 2006, 7, 53–58. [Google Scholar] [CrossRef] [PubMed]
  125. Oguro, K.; Yamane, J.; Yamamoto, T.; Ohnishi, K.; Oshima, S.I.; Imajoh, M. Draft genome sequence of Streptococcus parauberis strain SK-417, isolated from diseased Sebastes ventricosus in Kagoshima Japan. Genome Announc. 2014, 2, e00453-14. [Google Scholar] [CrossRef] [PubMed]
  126. Al Bulushi, I.M.; Poole, S.E.; Barlow, R.; Deeth, H.C.; Dykes, G.A. Speciation of Gram-positive bacteria in fresh and ambient-stored sub-tropical marine fish. Int. J. Food Microbiol. 2010, 138, 32–38. [Google Scholar] [CrossRef]
  127. Skaar, I.; Gaustad, P.; Tønjum, T.; Holm, B.; Stenwig, H. Streptococcus phocae sp. nov., a new species isolated from clinical specimens from seals. Int. J. Syst. Evol. Microbiol. 1994, 44, 646–650. [Google Scholar] [CrossRef]
  128. Henton, M.M.; Zapke, O.; Basson, P.A. Streptococcus phocae infections associated with starvation in Cape fur seals: Case report. J. S. Afr. Vet. Assoc. 1999, 70, 98–99. [Google Scholar] [CrossRef] [PubMed]
  129. Vossen, A.; Abdulmawjood, A.; Lämmler, C.; Weiss, R.; Siebert, U. Identification and molecular characterization of beta-hemolytic streptococci isolated from harbor seals (Phoca vitulina) and grey seals (Halichoerus grypus) of the German North and Baltic seas. J. Clin. Microbiol. 2004, 42, 469–473. [Google Scholar] [CrossRef]
  130. Kuiken, T.; Kennedy, S.; Barrett, T.; Van de Bildt, M.W.G.; Borgsteede, F.H.; Brew, S.D.; Codd, G.A.; Duck, C.; Deaville, R.; Eybatov, T.; et al. The 2000 canine distemper epidemic in Caspian seals (Phoca caspica): Pathology and analysis of contributory factors. Vet. Pathol. 2006, 43, 321–338. [Google Scholar] [CrossRef]
  131. Imai, D.; Jang, S.; Miller, M.; Conrad, P.A. Characterization of beta-hemolytic streptococci isolated from southern sea otters (Enhydra lutris nereis) stranded along the California coast. Vet. Microbiol. 2009, 136, 378–381. [Google Scholar] [CrossRef]
  132. Johnson, S.; Lowenstine, L.; Gulland, F.; Jang, S.; Imai, D.; Almy, F.; DeLong, R.; Gardner, I. Aerobic bacterial flora of the vagina and prepuce of California sea lions (Zalophus californianus) and investigation of associations with urogenital carcinomas. Vet. Microbiol. 2006, 114, 94–103. [Google Scholar] [CrossRef]
  133. Bartlett, G.; Smith, W.; Dominik, C.; Batac, F.; Dodd, E.; Byrne, B.A.; Jang, S.; Jessup, D.; Chantrey, J.; Miller, M. Prevalence, pathology, and risk factors associated with Streptococcus phocae infection in southern sea otters (Enhydra lutris nereis), 2004–2010. J. Wildl. Dis. 2016, 52, 1–9. [Google Scholar] [CrossRef]
  134. Facklam, R.; Elloitt, J.; Shewmaker, L.; Reingold, A. Identification and characterization of sporadic isolates of S. iniae from human. J. Clin. Microbiol. 2005, 43, 933–937. [Google Scholar] [CrossRef] [PubMed]
  135. Nitzan, Y.; Maayan, M.; Wajsman, C. Streptococcus group B isolates in a regional hospital area. Med. Microbiol. Immunol. 1980, 169, 21–30. [Google Scholar] [CrossRef]
  136. Tenenbaum, T.; Spellerberg, B.; Adam, R.; Vogel, M.; Kim, K.S.; Schroten, H. Streptococcus agalactiae invasion of human brain microvascular endothelial cells are promoted by the laminin-binding protein Lmb. Microbes Infect. 2007, 9, 714–720. [Google Scholar] [CrossRef] [PubMed]
  137. Oppegaard, O.; Mylvaganam, H.; Skrede, S.; Langeland, N.; Kittang, B.R. Sequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 273–277. [Google Scholar] [CrossRef] [PubMed]
  138. Chennapragada, S.S.; Ramphul, K.; Barnett, B.J.; Mejias, S.G.; Lohana, P. A rare case of Streptococcus dysgalactiae subsp. dysgalactiae human zoonotic infection. Cureu 2018, 10, e2901. [Google Scholar] [CrossRef]
  139. Koh, T.H.; Sng, L.H.; Yuen, S.M.; Thomas, C.K.; Tan, P.L.; Tan, S.H.; Wong, N.S. Streptococcal cellulitis following preparation of fresh raw seafood. Zoonoses Public Health 2009, 56, 206–208. [Google Scholar] [CrossRef]
  140. Bert, F.; Lambert-Zechovsky, N. A case of bacteremia caused by Streptococcus dysgalactiae. Eur. J. Clin. Microbiol. Infect. Dis. 1997, 16, 324–326. [Google Scholar] [CrossRef]
  141. Woo, P.C.; Teng, J.L.; Lau, S.K.; Lum, P.N.; Leung, K.W.; Wong, K.L.; Li, K.W.; Lam, K.C.; Yuen, K.Y. Analysis of a viridans group strain reveals a case of bacteremia due to Lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp. equisimilis in a patient with pyomyositis and reactive arthritis. J. Clin. Microbiol. 2003, 41, 613–618. [Google Scholar] [CrossRef]
  142. Fernández-Aceñero, M.J.; Fernández-López, P. Cutaneous lesions associated with bacteremia by Streptococcus dysgalactiae. J. Am. Acad. Dermatol. 2006, 55, S91–S92. [Google Scholar] [CrossRef]
  143. Di Domenico, E.G.; Toma, L.; Prignano, G.; Pelagalli, L.; Police, A.; Cavallotti, C.; Torelli, R.; Sanguinetti, M.; Ensoli, F. Misidentification of Streptococcus uberis as a human pathogen: A case report and literature review. Int. J. Infect. Dis. 2015, 33, 79–81. [Google Scholar] [CrossRef]
  144. Chen, C.-Y.; Chao, C.-B.; Bowser, P.R. Comparative histopathology of Streptococcus iniae and Streptococcus agalactiae-infected tilapia. Bull. Eur. Assoc. Fish Pathol. 2007, 27, 2–9. [Google Scholar]
  145. Martos-Sitcha, J.A.; Mancera, J.M.; Prunet, P.; Magnoni, L.J. Welfare and stressors in fish: Challenges facing aquaculture. Front. Physiol. 2020, 11, 162. [Google Scholar] [CrossRef]
  146. Shoemaker, C.A.; Evans, J.J.; Klesius, P.H. Density and dose: Factors affecting mortality of Streptococcus iniae infected tilapia (Oreochromis niloticus). Aquaclture 2000, 188, 229–235. [Google Scholar] [CrossRef]
  147. Alsaid, M.; Hassan, H.M.D.; Noordin, N.M.; Khairani Bejo, S.; Mohamed, Y.; Abuseliana, A.F. Environmental factors influencing the susceptibility of red hybrid tilapia (Oreochromis sp.) to Streptococcus agalactiae infection. Adv. Sci. Lett. 2013, 19, 3600–3604. [Google Scholar] [CrossRef]
  148. Chang, P.; Plumb, J. Effects of salinity on Streptococcus infection of Nile tilapia, Oreochromis niloticus. J. Appl. Aquac. 1996, 6, 39–45. [Google Scholar] [CrossRef]
  149. Bunch, E.C.; Bajerano, Y. The effect of environmental factors on the susceptibility of hybrid tilapia Oreochromis niloticus x Oreochromis aureus to streptococcosis. Isr. J. Aquac. 1997, 49, 56–61. [Google Scholar]
  150. Anshary, H.; Kurniawan, R.A.; Sriwulan, S.; Ramli, R.; Baxa, D.V. Isolation and molecular identification of the etiological agents of streptococcosis in Nile tilapia (Oreochromis niloticus) cultured in net cages in Lake Sentani, Papua, Indonesia. SpringerPlus 2014, 3, 627. [Google Scholar] [CrossRef]
  151. Chang, P.H.; Plumb, J.A. Histopathology of experimental Streptococcus sp. infection in tilapia, O. niloticus and channel catfish, Ictalarus punctatus. J. Fish Dis. 1996, 19, 235–241. [Google Scholar] [CrossRef]
  152. Hernández, E.; Figueroa, J.; Iregui, C. Streptococcosis on a red tilapia, Oreochromis sp., farm: A case study. J. Fish Dis. 2009, 32, 247–252. [Google Scholar] [CrossRef]
  153. Karamanoli, K.; Vokou, D.; Menkissoglu, U.; Constantinidou, H.I. Bacterial colonization of phyllosphere of Mediterranean aromatic plants. J. Chem. Ecol. 2000, 26, 2035–2048. [Google Scholar] [CrossRef]
  154. Inouye, S.; Takizawa, T.; Yamaguchi, H. Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J. Antimicrob. Chemother. 2001, 47, 565–573. [Google Scholar] [CrossRef] [PubMed]
  155. Abutbul, S.; Golan-Goldhirsh, A.; Barazani, O.; Zilberg, D. Use of Rosmarinus officinalis as a treatment against Streptococcus iniae in tilapia (Oreochromis sp.). Aquaculture 2004, 238, 97–105. [Google Scholar] [CrossRef]
  156. Zilberg, D.; Tal, A.; Froyman, N.; Abutbul, S.; Dudai, N.; Golan-Goldhirsh, A. Dried leaves of Rosmarinus officinalis as a treatment for streptococcosis in tilapia. J. Fish Dis. 2010, 33, 361–369. [Google Scholar] [CrossRef] [PubMed]
  157. Soltani, M.; Ghodratnama, M.; Taheri Mirghaed, A.; Zargar, A.; Rouhollahi, S.H. The effect of Zataria multiflora Boiss. and Rosmarinus officinalis essential oil on Streptococcus iniae isolated from rainbow trout farms. Vet. Microbiol. 2013, 9, 1–13. Available online: https://civilica.com/doc/646018/ (accessed on 11 September 2022).
  158. Soltani, M.; Ghodratnama, M.; Ebrahimzadeh-Mosavi, H.A.; Nikbakht-Brujeni, G.; Mohamadian, S.; Ghasemian, M. Shirazi thyme (Zataria multiflora Boiss) and Rosemary (Rosmarinus officinalis) essential oils repress expression of sagA, a streptolysin S-related gene in Streptococcus iniae. Aquaculture 2014, 430, 248–252. [Google Scholar] [CrossRef]
  159. Tafi, A.A.; Meshkini, S.; Tukmechi, A.; Alishahi, M.; Noori, F. Determination of component and in vitro anti streptococcal properties of Mentha piperita L.; Satureja khuzistanica Jamzad, Matricaria recutica L.; Zataria multiflora Boiss and Rosmarinus officinalis L. ethanolic extracts. Iran. J. Fish. Sci. 2020, 19, 1373–1383. [Google Scholar] [CrossRef]
  160. Yılmaz, S.; Ergün, S.; Soytaş, N. Herbal supplements are useful for preventing streptococcal disease during first feeding of tilapia fry, Oreochromis mossambicus. Isr. J. Aquac. 2013, 833, 195–204. [Google Scholar]
  161. Gültepe, N.; Bilen, S.; Yılmaz, S.; Güroy, D.; Aydın, S. Effects of herbs and spice on health status of tilapia (Oreochromis mossambicus) challenged with Streptococcus iniae. Acta Vet. 2014, 83, 125–131. [Google Scholar] [CrossRef]
  162. Alishahi, M.; Ghorbanpoor, M.; Najafzadeh, H.; Pashmforoosh, M. Antibacterial effects of some medical plant extracts on Aeromonas hydrophila, Yersinia ruckeri and Streptococcus iniae. Sci-Res. Iran. Vet. J. 2010, 6, 21–30. [Google Scholar]
  163. Owlia, P.; Rasooli, I.; Saderi, H. Antistreptococcal and antioxidant of essential oil from Matricaria chamomilla. Res. J. Biol. Sci. 2007, 2, 155–160. Available online: https://medwelljournals.com/abstract/?doi=rjbsci.2007.155.160 (accessed on 11 September 2022).
  164. Issabeagloo, E.; Kermanizadeh, P.; Taghizadieh, M.; Forughi, R. Antimicrobial effects of rosemary (Rosmarinus officinalis L.) essential oils against Staphyloccus spp. Afr. J. Microbiol. Res. 2012, 6, 5039–5042. [Google Scholar] [CrossRef]
  165. Tepe, B. Inhibitory effect of Satureja on certain types of organisms. Rec. Nat. Prod. 2015, 9, 1–18. [Google Scholar]
  166. Ghasemi Pirbalouti, A.; Nourafcan, H.; Solyamani-Babadi, E. Variation in chemical composition and antibacterial activity of essential oils from Bakhtiari Savory (Satureja bachtiarica Bunge.). J. Essent. Oil-Bear. Plants 2017, 20, 474–484. [Google Scholar] [CrossRef]
  167. Alsaid, M.; Daud, H.; Bejo, S.K.; Abuseliana, A. Antimicrobial activities of some culinary spice extracts against Streptococcus agalactiae and its prophylactic uses to prevent streptococcal infection in red hybrid tilapia (Oreochromis sp.). World J. Fish Mar. Sci. 2010, 2, 532–538. [Google Scholar]
  168. Bababaalian Amiri, A.; Azari Takami, G.; Afsharnasab, M.; Zargar, A. Effects of commercial herbal oil mixture on some hematological, biochemical and immunological parameters of rainbow trout (Oncorhynchus mykiss) and its preventive efficacy against Yersinia ruckeri infection. Iran. J. Fish. Sci. 2020, 19, 1304–1318. [Google Scholar] [CrossRef]
  169. Şimşek, M.; Duman, R. Investigation of effect of 1, 8-cineole on antimicrobial activity of chlorhexidine gluconate. Pharmacogn. Res. 2017, 9, 234–237. [Google Scholar] [CrossRef]
  170. Pamfil, D.; Vasile, C.; Tarţău, L.; Vereştiuc, L.; Poiată, A. pH-Responsive 2-hydroxyethyl methacrylate/citraconic anhydride–modified collagen hydrogels as ciprofloxacin carriers for wound dressings. J. Bioact. Compat. Polym. 2017, 32, 355–381. [Google Scholar] [CrossRef]
  171. Xu, J.; Zhou, F.; Ji, B.P.; Pei, R.S.; Xu, N. The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Lett. Appl. Microbiol. 2008, 47, 174–179. [Google Scholar] [CrossRef]
  172. Yılmaz, S.; Ergün, S.; Soytaş, N. Dietary supplementation of cumin (Cuminum cyminum) preventing streptococcal disease during first feeding of Mozambique tilapia (Oreochromis mossambicus). J. Biosci. Biotechnol. 2013, 2, 117–124. [Google Scholar]
  173. Yilmaz, S.; Ergün, S.; Turk, N. Effects of cumin-supplemented diets on growth and disease (Streptococcus iniae) resistance of tilapia (Oreochromis mossambicus). Isr. J. Aquac. 2012, 64, 768–772. [Google Scholar] [CrossRef]
  174. Gachkar, L.; Yadegari, D.; Rezaei, M.B.; Taghizadeh, M.; Astaneh, S.A.; Rasooli, I. Chemical and biological characteristics of Cuminum cyminum and Rosmarinus officinalis essential oils. Food Chem. 2007, 102, 898–904. [Google Scholar] [CrossRef]
  175. Moghimi, S.M.; Soltani, M.; Mirzargar, S.S.; Ghodratnama, M. Effects of Eucalyptus camaldulensis, Mentha pulegium and Aloe vera essences and chloramine T on growth behavior of Streptococcus iniae and Lactococcus garvieae the causes of streptococcosis/ lactococcosis in farmed rainbow trout (Onchorhynchus mykiss). J. Fish. 2013, 66, 106–118. [Google Scholar] [CrossRef]
  176. Tafi, A.A.; Meshkini, S.; Tukmechi, A.; Alishahi, M.; Noori, F. Therapeutic and histopathological effect of Aloe vera and Salvia officinalis hydroethanolic extracts against Streptococcus iniae in rainbow trout. Arch. Razi Inst. 2020, 75, 275–287. [Google Scholar] [CrossRef]
  177. Sserunkuma, P.; McGaw, L.J.; Nsahlai, I.V.; Van Staden, J. Selected southern African medicinal plants with low cytotoxicity and good activity against bovine mastitis pathogens. S. Afr. J. Bot. 2017, 111, 242–247. [Google Scholar] [CrossRef]
  178. Turker, H.; Yıldırım, A.B.; Karakaş, F.P. Sensitivity of bacteria isolated from fish to some medicinal plants. Turk. J. Fish. Aquat. Sci. 2009, 9, 181–186. [Google Scholar] [CrossRef]
  179. Na-Phatthalung, P.; Chusri, S.; Suanyuk, N.; Voravuthikunchai, S.P. In vitro and in vivo assessments of Rhodomyrtus tomentosa leaf extract as an alternative anti-streptococcal agent in Nile tilapia (Oreochromis niloticus L.). J. Med. Microbiol. 2017, 66, 430–439. [Google Scholar] [CrossRef] [PubMed]
  180. Najiah, M.; Nadirah, M.; Arief, Z.; Zahrol, S.; Tee, L.W.; Ranzi, A.D.; Amar, A.S.; Laith, A.A.; Mariam, M.; Suzana, S.; et al. Antibacterial activity of Malaysian edible herbs extracts on fish pathogenic bacteria. Res. J. Med. Plant 2011, 5, 772–778. [Google Scholar] [CrossRef]
  181. Pathirana, H.N.K.S.; Wimalasena, S.H.M.P.; De Silva, B.C.J.; Hossain, S.; Gang-Joon, H. Antibacterial activity of clove essential oil and eugenol against fish pathogenic bacteria isolated from cultured olive flounder (Paralichthys olivaceus). Slov. Vet. Res. 2019, 56, 31–38. [Google Scholar] [CrossRef]
  182. Gholipourkanani, H.; Buller, N.; Lymbery, A. In vitro antibacterial activity of four nano-encapsulated herbal essential oils against three bacterial fish pathogens. Aquac. Res. 2019, 50, 871–875. [Google Scholar] [CrossRef]
  183. Wimalasena, S.H.; Pathirana, H.N.; De Silva, B.C.; Hossain, S.; Heo, G.J. Antimicrobial activity of lavender (Lavendula rangustifolia) oil against fish pathogenic bacteria isolated from cultured olive flounder (Paralichthys olivaceus) in Korea. Indian J. Fish. 2018, 65, 52–56. [Google Scholar] [CrossRef]
  184. Chaudhry, N.M.A.; Tariq, P. Anti-microbial activity of Cinnamomum cassia against diverse microbial flora with its nutritional and medicinal impacts. Pak. J. Bot. 2006, 38, 169–174. [Google Scholar]
  185. Kareem, Z.H.; Abdelhadi, Y.M.; Christianus, A.; Karim, M.; Romano, N. Effects of some dietary crude plant extracts on the growth and gonadal maturity of Nile tilapia (Oreochromis niloticus) and their resistance to Streptococcus agalactiae infection. Fish Physiol. Biochem. 2016, 42, 757–769. [Google Scholar] [CrossRef] [PubMed]
  186. Guo, W.L.; Wang, W.H.; Hu, W.T.; Zhou, Y.C. Antibacterial synergisms of Ji Xue Teng, Spatholobus suberectus, extract and selected antibiotics against Streptococcus agalactiae from Nile tilapia, Oreochromis niloticus (L.), in Vitro and in Vivo. J. World Aquac. Soc. 2018, 49, 1002–1013. [Google Scholar] [CrossRef]
  187. Nayak, Y.; Abhilash, D. Protection of cyclophosphamide induced myelosuppression by alcoholic extract of Pimenta dioica leaves in mice. Pharmacologyonline 2008, 3, 719–723. [Google Scholar]
  188. Krishnamoorthy, B.; Rema, J. Allspice. In Handbook of Herbs and Spices; Peter, K.V., Ed.; Woodhead Publishing: Boca Raton, FL, USA, 2004; pp. 117–139, 391–416. [Google Scholar]
  189. Shylaja, M.R.; Peter, K.V. The functional role of herbal spices. In Handbook of Herbs and Spices (Peter editor); Woodhead Publishing Limited: Boca Raton, FL, USA, 2004; pp. 26–45. [Google Scholar]
  190. Gopinath, S.M.; Suneetha, T.B.; Mruganka, V.D.; Ananda, S. Chemical profiling and antibacterial activity of Punica granatum L. against pathogens causing bovine mastitis. J. Chem. Pharm. Res. 2011, 3, 514–518. [Google Scholar]
  191. Ko, M.O.; Ko, J.Y.; Kim, M.B.; Lim, S.B. Antibacterial activity of isothiocyanates from cruciferous vegetables against pathogenic bacteria in olive flounder. Korean J. Food Preserv. 2015, 22, 886–892. [Google Scholar] [CrossRef]
  192. Kim, J.H.; Kim, S.B.; Hwang, H.J.; Kim, Y.M.; Lee, M.S. Antibacterial property of Ecklonia cava extract against marine bacterial pathogens. J. Food Hyg. Saf. 2016, 31, 380–385. [Google Scholar] [CrossRef]
  193. Eom, S.H.; Santos, J.A.; Kim, J.H.; Jung, W.K.; Kim, D.H.; Kim, Y.M. In vitro antibacterial and synergistic activity of an Ecklonia cava extract against antibiotic-resistant Streptococcus parauberis. Fish. Aquat. Sci. 2015, 18, 241–247. [Google Scholar] [CrossRef]
  194. Olusola, S.E.; Fakoya, S.; Omage, I.B. Antimicrobial activity of leaf extracts of Neem (Azadrichta indica) and Tumeric (Curcuma longa) rhizome against some pathogens isolated from Clarias gariepinus. J. Adv. Microbiol. 2017, 3, 238–245. [Google Scholar]
  195. Saeidi asl, M.R.; Adel, M.; Caipang, C.M.A.; Dawood, M.A.O. Immunological responses and disease resistance of rainbow trout (Oncorhynchus mykiss) juveniles following dietary administration of stinging nettle (Urtica dioica). Fish Shellfish. Immunol. 2017, 71, 230–238. [Google Scholar] [CrossRef]
  196. Safari, O.; Sarkheil, M.; Paolucci, M. Dietary administration of ferula (Ferula asafoetida) powder as a feed additive in diet of koi carp, Cyprinus carpio koi: Effects on hemato-immunological parameters, mucosal antibacterial activity, digestive enzymes, and growth performance. Fish Physiol. Biochem. 2019, 45, 1277–1288. [Google Scholar] [CrossRef] [PubMed]
  197. Zargar, A.; Mazandarani, M.; Hoseini, S.M. Effects of safflower (Carthamus tinctorius) extract on serum antibacterial activity of rainbow trout (Oncorhynchus mykiss) against Aeromonas hydrophila, Streptococcus iniae and Yersinia ruckeri. Int. J. Aquat. Biol. 2018, 6, 1–7. [Google Scholar] [CrossRef]
  198. Kang, M.; Kim, M.B.; Kim, J.H.; Ko, Y.H.; Lim, S.B. Integral antioxidative capacity and antimicrobial activity of pressurized liquid extracts from 40 selected plant species. J. Korean Soc. Food Sci. Nutr. 2010, 39, 1249–1256. [Google Scholar] [CrossRef]
  199. Dharaneedharan, S.; Harikrishanan, R.; Balasundaram, C.; Heo, M.S. In vitro antioxidant and antimicrobial activity of Rubus coreanus ethanolic extract, a potent biotherapeutic component for aquaculture. Isr. J. Aquac. 2013, 9, 1–7. [Google Scholar]
  200. Pathirana, H.N.K.S.; Wimalasena, S.H.M.P.; De Silva, B.C.J.; Hossain, S.; Gang-Joon, H. Determination of the in vitro effect of lemongrass (Cymbopogon flexuosus) oil against fish pathogenic bacteria isolated from cultured olive flounder (Paralichthys olivaceus). Slov. Vet. Res. 2019, 56, 125–131. [Google Scholar] [CrossRef]
  201. Ham, Y.; Yang, J.; Choi, W.S.; Ahn, B.J.; Park, M.J. Antibacterial activity of essential oils from Pinaceae leaves against fish pathogens. J. Korean Wood Sci. Technol. 2020, 48, 527–547. [Google Scholar] [CrossRef]
  202. Apraku, A.; Liu, L.; Leng, X.; Rupia, E.J.; Ayisi, C.L. Evaluation of blended virgin coconut oil and fish oil on growth performance and resistance to Streptococcus iniae challenge of Nile tilapia (Oreochromis niloticus). Egypt. J. Basic Appl. Sci. 2017, 4, 175–184. [Google Scholar] [CrossRef] [Green Version]
  203. DebMandal, M.; Mandal, S. Coconut (Cocos nucifera L.: Arecaceae): In health promotion and disease prevention. Asian Pac. J. Trop. Med. 2011, 4, 241–247. [Google Scholar] [CrossRef]
  204. Sharif Rohani, M.; Pourgholam, R.; Haghighi, M. Evaluation the effects of different levels of Echinacea purpurea extract on the immunity responses, biochemical and hematological indices and disease resistance against Streptococcus iniae in rainbow trout (Oncorhynchus mykiss). Iran. J. Aquat. Anim. Health 2016, 2, 1–13. [Google Scholar] [CrossRef]
  205. Rufchaei, R.; Mirvaghefi, A.; Hoseinifar, S.H.; Valipour, A.; Nedaei, S. Effects of dietary administration of water hyacinth (Eichhornia crassipes) leaves extracts on innate immune parameters, antioxidant defence and disease resistance in rainbow trout (Oncorhynchus mykiss). Aquaculture 2019, 515, 734533. [Google Scholar] [CrossRef]
  206. Aboul-Enein, A.M.; Shanab, S.M.; Shalaby, E.A.; Zahran, M.M.; Lightfoot, D.A.; El-Shemy, H.A. Cytotoxic and antioxidant properties of active principals isolated from water hyacinth against four cancer cells lines. BMC Complement. Altern. Med. 2014, 14, 397. [Google Scholar] [CrossRef] [PubMed]
  207. Chantiratikul, P.; Meechai, P.; Nakbanpotec, W. Antioxidant activities and phenolic contents of extracts from Salvinia molesta and Eichornia crassipes. Res. J. Biol. Sci. 2009, 4, 1113–1117. [Google Scholar]
  208. Surendraraj, A.; Farvin, K.S.; Anandan, R. Antioxidant potential of water hyacinth (Eichornia crassipes): In vitro antioxidant activity and phenolic composition. J. Aquat. Food Prod. Technol. 2013, 22, 11–26. [Google Scholar] [CrossRef]
  209. Rattanachaikunsopon, P.; Phumkhachorn, P. Bacteriostatic effect of flavonoids isolated from leaves of Psidium guajava on fish pathogens. Fitoterapia 2007, 78, 434–436. [Google Scholar] [CrossRef] [PubMed]
  210. Rattanachaikunsopon, P.; Phumkhachorn, P. Prophylactic effect of Andrographis paniculata extracts against Streptococcus agalactiae infection in Nile tilapia (Oreochromis niloticus). J. Biosci. Bioeng. 2009, 107, 579–582. [Google Scholar] [CrossRef] [PubMed]
  211. Chalabian, F.; Sharif-Nia, F.; Katouzian, F. Antimicrobial effects of methanol, ethanol and water of six species of Papaver Iran on a number of pathogenic bacteria. J. Sci. 2009, 19, 74. [Google Scholar]
  212. Neto, C.C.; Owens, C.W.; Langfield, R.D.; Comeau, A.B.; Onge, J.S.; Vaisberg, A.J.; Hammond, G.B. Antibacterial activity of some Peruvian medicinal plants from the Callejon de Huaylas. J. Ethnopharmacol. 2002, 79, 133–138. [Google Scholar] [CrossRef]
  213. Borisutpeth, P.; Kanbutra, P.; Weerakhun, S.; Sarachoo, K.; Porntrakulpipat, S. Antibacterial activity of Thai medicinal plant extracts on Aeromonas hydrophila and Streptococcus agalactiae isolated from diseased tilapia (Oreochromis niloticus). In Proceedings of the Abstracts of 31st Congress on Science and Technology of Thailand at Suranaree University of Technology, Khon Kaen, Thailand, 18–20 October 2005. [Google Scholar]
  214. Mubarack, H.M.; Doss, A.; Dhanabalan, R.; Venkataswamy, R. In vitro antimicrobial effects of some selected plants against bovine mastitis pathogens. Hygeia J. Drugs Med. 2011, 3, 71–75. [Google Scholar]
  215. Kamble, M.T.; Gallardo, W.; Yakuitiyage, A.; Chavan, B.R.; Rusydi, R.; Rahma, A. Antimicrobial activity of bioactive herbal extracts against Streptococcus agalactiae biotype 2. Int. J. Basic Appl. Biol. 2014, 2, 152–155. [Google Scholar]
  216. Rattanachaikunsopon, P.; Phumkhachorn, P. Effect of Cratoxylum formosum on innate immune response and disease resistance against Streptococcus agalactiae in tilapia Oreochromis niloticus. Fish. Sci. 2010, 76, 653–659. [Google Scholar] [CrossRef]
  217. Wu, Y.R.; Gong, Q.F.; Fang, H.; Liang, W.W.; Chen, M.; He, R.J. Effect of Sophora flavescens on non-specific immune response of tilapia (GIFT Oreochromis niloticus) and disease resistance against Streptococcus agalactiae. Fish Shellfish Immunol. 2013, 34, 220–227. [Google Scholar] [CrossRef] [PubMed]
  218. Van Doan, H.; Hoseinifar, S.H.; Sringarm, K.; Jaturasitha, S.; Yuangsoi, B.; Dawood, M.A.; Esteban, M.Á.; Ringø, E.; Faggio, C. Effects of Assam tea extract on growth, skin mucus, serum immunity and disease resistance of Nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae. Fish Shellfish Immunol. 2019, 93, 428–435. [Google Scholar] [CrossRef] [PubMed]
  219. Park, H.R.; Hwang, D.; Suh, H.J.; Yu, K.W.; Kim, T.Y.; Shin, K.S. Antitumor and antimetastatic activities of rhamnogalacturonan-II-type polysaccharide isolated from mature leaves of green tea via activation of macrophages and natural killer cells. Int. J. Biol. Macromol. 2017, 99, 179–186. [Google Scholar] [CrossRef] [PubMed]
  220. Jeszka-Skowron, M.; Zgoła-Grześkowiak, A.; Frankowski, R. Cistus incanus a promising herbal tea rich in bioactive compounds: LC–MS/MS Determination of catechins, flavonols, phenolic acids and alkaloids—A comparison with Camellia sinensis, Rooibos and Hoan ngoc herbal tea. J. Food Compos. Anal. 2018, 74, 71–81. [Google Scholar] [CrossRef]
  221. Lee, M.K.; Kim, H.W.; Lee, S.H.; Kim, Y.J.; Asamenew, G.; Choi, J.; Lee, J.W.; Jung, H.A.; Yoo, S.M.; Kim, J.B. Characterization of catechins, theaflavins, and flavonols by leaf processing step in green and black teas (Camellia sinensis) using UPLC-DAD-QToF/MS. Eur. Food Res. Technol. 2019, 245, 997–1010. [Google Scholar] [CrossRef]
  222. Pereira, V.P.; Knor, F.J.; Vellosa, J.C.R.; Beltrame, F.L. Determination of phenolic compounds and antioxidant activity of green, black and white teas of Camellia sinensis (L.) Kuntze, Theaceae. Rev. Bras. De Plantas Med. 2014, 16, 490–498. [Google Scholar] [CrossRef]
  223. Abarike, E.D.; Jian, J.; Tang, J.; Cai, J.; Yu, H.; Chen, L. Traditional Chinese medicine enhances growth, immune response, and resistance to Streptococcus agalactiae in Nile tilapia. J. Aquat. Anim. Health 2019, 31, 46–55. [Google Scholar] [CrossRef]
  224. Guo, W.L.; Deng, H.W.; Wang, S.F.; Zhou, Z.H.; Sun, Y.; Chen, X.F.; Wang, J.H.; Zhou, Y.C. In vitro and in vivo screening of herbal extracts against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus). Aquaculture 2019, 503, 412–421. [Google Scholar] [CrossRef]
  225. Baskaran, S.A.; Kazmer, G.W.; Hinckley, L.; Andrew, S.M.; Venkitanarayanan, K. Antibacterial effect of plant-derived antimicrobials on major bacterial mastitis pathogens in vitro. J. Dairy Sci. 2009, 92, 1423–1429. [Google Scholar] [CrossRef]
  226. Peng, S.; Dai, W.; Yu, H.; Wang, Y.; Wang, X.; Sun, S. Antibacterial activity of aqueous and ethanolic extracts of Portulaca oleracea L. and Taraxacum mongolicum against pathogenic bacteria of cow mastitis. Int. J. Appl. Res. Vet. Med. 2014, 12, 210–213. [Google Scholar] [CrossRef]
  227. Kachhawa, J.P.; Singh, A.P.; Chahar, A.; Dadhich, H.; Marwaha, S.; Savita Kumar, S. In vitro antibacterial activities of Withania somnifera, Citrullus colocynthis and Piper nigrum against subclinical mastitis bacterial pathogens of cows. J. Entomol. Zool. Stud. 2019, 7, 950–955. [Google Scholar]
  228. Martins, N.; Barros, L.; Santos-Buelga, C.; Henriques, M.; Silva, S.; Ferreira, I.C. Evaluation of bioactive properties and phenolic compounds in different extracts prepared from Salvia officinalis L. Food Chem. 2015, 170, 378–385. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  229. Harjanti, D.W.; Ciptaningtyas, R.; Wahyono, F. Phytochemical properties and antibacterial activity of Ageratum conyzoides, Piper betle, Muntinga calabura and Curcuma domestica against mastitis bacteria isolates. IOP Conf. Ser. Earth Environ. Sci. 2019, 247. [Google Scholar] [CrossRef]
  230. Zizovic, I.; Ivanovic, J.; Misic, D.; Stamenic, M.; Djordjevic, S.; Kukic-Markovic, J.; Petrovic, S.D. SFE as a superior technique for isolation of extracts with strong antibacterial activities from lichen Usnea barbata L. J. Supercrit. Fluids 2012, 72, 7–14. [Google Scholar] [CrossRef]
  231. Montironi, I.D.; Cariddi, L.N.; Reinoso, E.B. Evaluation of the antimicrobial efficacy of Minthostachys verticillata essential oil and limonene against Streptococcus uberis strains isolated from bovine mastitis. Rev. Argent. De Microbiol. 2016, 48, 210–216. [Google Scholar] [CrossRef]
  232. Sharma, A.K.; Kumar, A.; Yadav, S.K.; Rahal, A. Studies on antimicrobial and immunomodulatory effects of hot aqueous extract of Acacia nilotica L. leaves against common veterinary pathogens. Vet. Med. Int. 2014, 9, 747042. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Van Doan, H.; Soltani, M.; Leitão, A.; Shafiei, S.; Asadi, S.; Lymbery, A.J.; Ringø, E. Streptococcosis a Re-Emerging Disease in Aquaculture: Significance and Phytotherapy. Animals 2022, 12, 2443. https://doi.org/10.3390/ani12182443

AMA Style

Van Doan H, Soltani M, Leitão A, Shafiei S, Asadi S, Lymbery AJ, Ringø E. Streptococcosis a Re-Emerging Disease in Aquaculture: Significance and Phytotherapy. Animals. 2022; 12(18):2443. https://doi.org/10.3390/ani12182443

Chicago/Turabian Style

Van Doan, Hien, Mehdi Soltani, Alexandra Leitão, Shafigh Shafiei, Sepideh Asadi, Alan J. Lymbery, and Einar Ringø. 2022. "Streptococcosis a Re-Emerging Disease in Aquaculture: Significance and Phytotherapy" Animals 12, no. 18: 2443. https://doi.org/10.3390/ani12182443

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop